NF-kappaB-mediated	B-cell_type
up-regulation	I-cell_type
of	O
Bcl-x	B-protein
and	O
Bfl-1/A1	B-protein
is	O
required	O
for	O
CD40	B-protein
survival	O
signaling	O
in	O
B	B-cell_type
lymphocytes	I-cell_type
.	O

Activation	O
of	O
CD40	B-protein
is	O
essential	O
for	O
thymus-dependent	O
humoral	O
immune	O
responses	O
and	O
rescuing	O
B	B-cell_type
cells	I-cell_type
from	O
apoptosis	O
.	O

Many	O
of	O
the	O
effects	O
of	O
CD40	B-protein
are	O
believed	O
to	O
be	O
achieved	O
through	O
altered	O
gene	O
expression	O
.	O

In	O
addition	O
to	O
Bcl-x	B-protein
,	O
a	O
known	O
CD40-regulated	B-protein
antiapoptotic	I-protein
molecule	I-protein
,	O
we	O
identified	O
a	O
related	O
antiapoptotic	B-protein
molecule	I-protein
,	O
A1/Bfl-1	B-protein
,	O
as	O
a	O
CD40-inducible	B-DNA
gene	I-DNA
.	O

Inhibition	O
of	O
the	O
NF-kappaB	B-protein
pathway	O
by	O
overexpression	O
of	O
a	O
dominant-active	O
inhibitor	O
of	O
NF-kappaB	B-protein
abolished	O
CD40	B-protein
-induced	O
up-regulation	O
of	O
both	O
the	O
Bfl-1	B-protein
and	O
Bcl-x	B-protein
genes	O
and	O
also	O
eliminated	O
the	O
ability	O
of	O
CD40	B-protein
to	O
rescue	O
Fas	B-protein
-induced	O
cell	O
death	O
.	O

Within	O
the	O
upstream	B-DNA
promoter	I-DNA
region	I-DNA
of	O
Bcl-x	B-protein
,	O
a	O
potential	O
NF-kappaB-binding	B-DNA
sequence	I-DNA
was	O
found	O
to	O
support	O
NF-kappaB	B-protein
-dependent	O
transcriptional	O
activation	O
.	O

Furthermore	O
,	O
expression	O
of	O
physiological	O
levels	O
of	O
Bcl-x	B-cell_type
protected	I-cell_type
B	I-cell_type
cells	I-cell_type
from	O
Fas-mediated	O
apoptosis	O
in	O
the	O
absence	O
of	O
NF-kappaB	B-protein
signaling	O
.	O

Thus	O
,	O
our	O
results	O
suggest	O
that	O
CD40	B-protein
-mediated	O
cell	O
survival	O
proceeds	O
through	O
NF-kappaB	B-protein
-dependent	O
up-regulation	O
of	O
Bcl-2	B-protein
family	I-protein
members	I-protein
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

96	NULL
,	NULL
pp	NULL
.	NULL

9136-9141	NULL
,	NULL
August	NULL
1999	NULL
Cell	NULL
Biology	NULL
up-regulation	NULL
of	NULL
Bcl-x	NULL
and	NULL
Bfl-1/Al	NULL
is	NULL
required	NULL
for	NULL
CD40	NULL
survival	NULL
signaling	NULL
in	NULL
B	NULL
lymphocytes	NULL
Ho	NULL
H.	NULL
LeE*	NULL
,	NULL
HalIR	NULL
DADGOSTAR*	NULL
,	NULL
QINGWEN	NULL
CHENG	NULL
,	NULL
JUuNYAN	NULL
SHU	NULL
,	NULL
aND	NULL
GEnHONG	NULL
CHENGT	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Molecular	NULL
Genetics	NULL
,	NULL
Jonsson	NULL
Comprehensive	NULL
Cancer	NULL
Center	NULL
,	NULL
and	NULL
Molecular	NULL
Biology	NULL
Institute	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
90095	NULL
Communicated	NULL
by	NULL
Luiz	NULL
Birnbaumer	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
,	NULL
June	NULL
10	NULL
,	NULL
1999	NULL
(	NULL
received	NULL
for	NULL
review	NULL
May	NULL
6	NULL
,	NULL
1999	NULL
)	NULL
ABSTRACT	NULL
Activation	NULL
of	NULL
CD40	NULL
is	NULL
essential	NULL
for	NULL
thymus-dependent	NULL
humoral	NULL
immune	NULL
responses	NULL
and	NULL
rescuing	NULL
B	NULL
cells	NULL
from	NULL
apoptosis	NULL
.	NULL

Many	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
CD40	NULL
are	NULL
believed	NULL
to	NULL
be	NULL
achieved	NULL
through	NULL
altered	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
Bcl-x	NULL
,	NULL
a	NULL
known	NULL
CD40-regulated	NULL
antiapoptotic	NULL
molecule	NULL
,	NULL
we	NULL
identified	NULL
a	NULL
related	NULL
antiapoptotic	NULL
molecule	NULL
,	NULL
A1/Bfl-1	NULL
,	NULL
as	NULL
a	NULL
CD40-inducible	NULL
gene	NULL
.	NULL

Inhibition	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
pathway	NULL
by	NULL
overexpression	NULL
of	NULL
a	NULL
dominant-active	NULL
inhibitor	NULL
of	NULL
NF-B	NULL
abolished	NULL
CD40-induced	NULL
up-regulation	NULL
of	NULL
both	NULL
the	NULL
Bfl-1	NULL
and	NULL
Bcl-x	NULL
genes	NULL
and	NULL
also	NULL
eliminated	NULL
the	NULL
ability	NULL
of	NULL
CD40	NULL
to	NULL
rescue	NULL
Fas-induced	NULL
cell	NULL
death	NULL
.	NULL

Within	NULL
the	NULL
upstream	NULL
promoter	NULL
region	NULL
of	NULL
Bcl-x	NULL
,	NULL
a	NULL
potential	NULL
sequence	NULL
was	NULL
found	NULL
to	NULL
support	NULL
NF-	NULL
«	NULL
B-dependent	NULL
transcriptional	NULL
activation	NULL
.	NULL

Furthermore	NULL
,	NULL
expression	NULL
of	NULL
physiological	NULL
levels	NULL
of	NULL
Bel-x	NULL
protected	NULL
B	NULL
cells	NULL
from	NULL
Fas-mediated	NULL
apoptosis	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
signaling	NULL
.	NULL

Thus	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
CD4O0-mediated	NULL
cell	NULL
survival	NULL
proceeds	NULL
through	NULL
NF-rB-dependent	NULL
up-regulation	NULL
of	NULL
Bcel-2	NULL
family	NULL
members	NULL
.	NULL

CD40	NULL
is	NULL
a	NULL
50-kDa	NULL
glycoprotein	NULL
member	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
receptor	NULL
(	NULL
TNFR	NULL
)	NULL
superfamily	NULL
,	NULL
a	NULL
family	NULL
of	NULL
type	NULL
I	NULL
receptors	NULL
with	NULL
more	NULL
than	NULL
20	NULL
known	NULL
members	NULL
,	NULL
which	NULL
mediates	NULL
a	NULL
diverse	NULL
array	NULL
of	NULL
biological	NULL
processes	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Studies	NULL
with	NULL
X-linked	NULL
hyper-IgM	NULL
syndrome	NULL
(	NULL
HIGMX	NULL
)	NULL
,	NULL
a	NULL
genetic	NULL
defect	NULL
in	NULL
the	NULL
corresponding	NULL
CD40	NULL
ligand	NULL
(	NULL
CD4O0L	NULL
)	NULL
gene	NULL
,	NULL
and	NULL
with	NULL
mice	NULL
lacking	NULL
either	NULL
the	NULL
CD40	NULL
or	NULL
CD40L	NULL
gene	NULL
have	NULL
demonstrated	NULL
that	NULL
interaction	NULL
between	NULL
CD40	NULL
and	NULL
CD4O0L	NULL
during	NULL
T	NULL
and	NULL
B	NULL
cell	NULL
contact	NULL
is	NULL
essential	NULL
for	NULL
all	NULL
events	NULL
in	NULL
thymus-dependent	NULL
antigen	NULL
responses	NULL
such	NULL
as	NULL
Ig	NULL
production	NULL
,	NULL
isotype	NULL
switching	NULL
,	NULL
somatic	NULL
hypermutation	NULL
,	NULL
and	NULL
induction	NULL
of	NULL
B	NULL
cell	NULL
memory	NULL
(	NULL
2-5	NULL
)	NULL
.	NULL

Recently	NULL
published	NULL
studies	NULL
indicate	NULL
that	NULL
CD40/CDA4O0L	NULL
interactions	NULL
also	NULL
play	NULL
important	NULL
roles	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
macrophages	NULL
,	NULL
natural	NULL
killer	NULL
cells	NULL
,	NULL
and	NULL
endothelial	NULL
cells	NULL
(	NULL
6	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
mechanisms	NULL
for	NULL
these	NULL
biological	NULL
effects	NULL
of	NULL
CD40/	NULL
CD40L	NULL
interactions	NULL
,	NULL
however	NULL
,	NULL
remain	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

An	NULL
important	NULL
aspect	NULL
of	NULL
CD40	NULL
signaling	NULL
in	NULL
B	NULL
cells	NULL
is	NULL
its	NULL
ability	NULL
to	NULL
control	NULL
apoptosis	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Isolated	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
,	NULL
which	NULL
spontaneously	NULL
undergo	NULL
apoptosis	NULL
in	NULL
culture	NULL
,	NULL
are	NULL
capable	NULL
of	NULL
surviving	NULL
for	NULL
extended	NULL
periods	NULL
when	NULL
treated	NULL
with	NULL
anti-CD40	NULL
antibodies	NULL
or	NULL
CD4O0L	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
CD40	NULL
is	NULL
known	NULL
to	NULL
rescue	NULL
immature	NULL
B	NULL
cells	NULL
,	NULL
such	NULL
as	NULL
WEHI	NULL
231	NULL
cells	NULL
,	NULL
and	NULL
mature	NULL
B	NULL
cells	NULL
from	NULL
surface	NULL
IgM	NULL
(	NULL
sIgM	NULL
)	NULL
and	NULL
Fas-mediated	NULL
apoptosis	NULL
,	NULL
respectively	NULL
(	NULL
8-10	NULL
)	NULL
.	NULL

Many	NULL
studies	NULL
indicate	NULL
that	NULL
the	NULL
antiapoptotic	NULL
function	NULL
of	NULL
CD40	NULL
is	NULL
mediated	NULL
by	NULL
up-regulated	NULL
expression	NULL
of	NULL
the	NULL
Bcl-x	NULL
,	NULL
gene	NULL
,	NULL
an	NULL
antiapoptotic	NULL
member	NULL
of	NULL
the	NULL
Bel-2	NULL
family	NULL
of	NULL
proteins	NULL
(	NULL
11-13	NULL
)	NULL
.	NULL

This	NULL
family	NULL
includes	NULL
other	NULL
antiapoptotic	NULL
members	NULL
such	NULL
as	NULL
Bfl-1/A1	NULL
,	NULL
Mcl-1	NULL
,	NULL
and	NULL
Bel-w	NULL
,	NULL
as	NULL
well	NULL
as	NULL
proapoptotic	NULL
members	NULL
such	NULL
as	NULL
Bax	NULL
,	NULL
Bad	NULL
,	NULL
Bid	NULL
,	NULL
and	NULL
the	NULL
alternatively	NULL
spliced	NULL
Bcl-xs	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Studies	NULL
show	NULL
that	NULL
overexpression	NULL
of	NULL
exogenous	NULL
Bcl-x	NULL
,	NULL
(	NULL
hereafter	NULL
referred	NULL
to	NULL
as	NULL
Bel-x	NULL
)	NULL
is	NULL
capable	NULL
of	NULL
preventing	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

PNAS	NULL
is	NULL
available	NULL
online	NULL
at	NULL
www.pnas.org	NULL
.	NULL

9136	NULL
B	NULL
cell	NULL
apoptosis	NULL
by	NULL
various	NULL
stimuli	NULL
such	NULL
as	NULL
Fas	NULL
activation	NULL
,	NULL
sIgM	NULL
crosslinking	NULL
,	NULL
and	NULL
exposure	NULL
to	NULL
various	NULL
chemical	NULL
inducers	NULL
of	NULL
cell	NULL
death	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Studies	NULL
by	NULL
our	NULL
laboratory	NULL
,	NULL
as	NULL
well	NULL
as	NULL
those	NULL
of	NULL
others	NULL
,	NULL
have	NULL
determined	NULL
that	NULL
TNF	NULL
receptor-associated	NULL
factor	NULL
(	NULL
TRAF	NULL
)	NULL
adapter	NULL
proteins	NULL
,	NULL
most	NULL
notably	NULL
TRAF	NULL
2	NULL
,	NULL
are	NULL
crucial	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
CD4O0-signaling	NULL
pathways	NULL
such	NULL
as	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
(	NULL
SAPK	NULL
)	NULL
pathways	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
pathway	NULL
activates	NULL
a	NULL
number	NULL
of	NULL
related	NULL
transcription	NULL
factors	NULL
collectively	NULL
known	NULL
as	NULL
the	NULL
Rel	NULL
family	NULL
,	NULL
including	NULL
five	NULL
mammalian	NULL
members	NULL
:	NULL
NF-	NULL
«	NULL
B1	NULL
(	NULL
p50	NULL
)	NULL
,	NULL
NF-	NULL
«	NULL
B2	NULL
(	NULL
p52	NULL
)	NULL
,	NULL
c-Rel	NULL
,	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
,	NULL
and	NULL
ReIB	NULL
(	NULL
17	NULL
)	NULL
.	NULL

These	NULL
molecules	NULL
typically	NULL
exist	NULL
as	NULL
inactive	NULL
hetero-	NULL
/homodimers	NULL
in	NULL
the	NULL
cytoplasm	NULL
complexed	NULL
with	NULL
an	NULL
inhibitory	NULL
IxB	NULL
(	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
molecule	NULL
.	NULL

Studies	NULL
with	NULL
fibroblast	NULL
cell	NULL
lines	NULL
from	NULL
RelA-deficient	NULL
mice	NULL
or	NULL
cell	NULL
lines	NULL
overexpressing	NULL
a	NULL
dominant-active	NULL
IxB-	NULL
«	NULL
mutant	NULL
,	NULL
with	NULL
the	NULL
critical	NULL
serines	NULL
at	NULL
positions	NULL
32	NULL
and	NULL
36	NULL
converted	NULL
to	NULL
alanine	NULL
residues	NULL
,	NULL
demonstrate	NULL
that	NULL
the	NULL
NF-	NULL
«	NULL
B-signaling	NULL
pathway	NULL
plays	NULL
an	NULL
essential	NULL
antiapoptotic	NULL
role	NULL
and	NULL
that	NULL
this	NULL
function	NULL
requires	NULL
protein	NULL
synthesis	NULL
(	NULL
18-20	NULL
)	NULL
.	NULL

In	NULL
an	NULL
effort	NULL
to	NULL
identify	NULL
genes	NULL
up-regulated	NULL
by	NULL
CD40	NULL
signaling	NULL
,	NULL
our	NULL
laboratory	NULL
discovered	NULL
,	NULL
through	NULL
representational	NULL
difference	NULL
analysis	NULL
screening	NULL
,	NULL
that	NULL
Bfl-1/A1	NULL
,	NULL
an	NULL
antiapoptotic	NULL
Bcl-2	NULL
family	NULL
member	NULL
,	NULL
was	NULL
up-regulated	NULL
by	NULL
CD40	NULL
activation	NULL
.	NULL

Along	NULL
with	NULL
Bcl-x	NULL
,	NULL
this	NULL
represents	NULL
the	NULL
second	NULL
Bel-2	NULL
relative	NULL
known	NULL
to	NULL
be	NULL
up-regulated	NULL
by	NULL
CD40	NULL
signaling	NULL
.	NULL

Using	NULL
cell	NULL
lines	NULL
overexpressing	NULL
a	NULL
super-repressor	NULL
,	NULL
dominant-active	NULL
IxB	NULL
,	NULL
it	NULL
was	NULL
established	NULL
that	NULL
the	NULL
NF-	NULL
«	NULL
B-signaling	NULL
pathway	NULL
is	NULL
essential	NULL
for	NULL
CD40-induced	NULL
up-regulation	NULL
of	NULL
both	NULL
of	NULL
these	NULL
antiapoptotic	NULL
Bcl-2	NULL
family	NULL
members	NULL
as	NULL
well	NULL
as	NULL
for	NULL
CD4O0-mediated	NULL
rescue	NULL
of	NULL
Fas-induced	NULL
B	NULL
cell	NULL
apoptosis	NULL
.	NULL

Our	NULL
results	NULL
also	NULL
identify	NULL
a	NULL
potential	NULL
NF-	NULL
«	NULL
B-binding	NULL
region	NULL
within	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
Bcl-x	NULL
gene	NULL
,	NULL
which	NULL
binds	NULL
NF-kB	NULL
subunits	NULL
and	NULL
supports	NULL
NF-	NULL
«	NULL
B-mediated	NULL
transcription	NULL
,	NULL
as	NULL
assessed	NULL
through	NULL
reporter	NULL
gene	NULL
analysis	NULL
.	NULL

Finally	NULL
,	NULL
by	NULL
using	NULL
cell	NULL
lines	NULL
expressing	NULL
various	NULL
levels	NULL
of	NULL
exogenous	NULL
Bcl-x	NULL
,	NULL
it	NULL
was	NULL
also	NULL
shown	NULL
that	NULL
the	NULL
levels	NULL
of	NULL
Bcl-x	NULL
induced	NULL
by	NULL
CD40	NULL
activation	NULL
are	NULL
sufficient	NULL
to	NULL
protect	NULL
against	NULL
Fas-mediated	NULL
cell	NULL
death	NULL
in	NULL
cells	NULL
lacking	NULL
functional	NULL
NF-KB	NULL
activity	NULL
.	NULL

Thus	NULL
,	NULL
our	NULL
studies	NULL
provide	NULL
a	NULL
crucial	NULL
link	NULL
in	NULL
CD40-mediated	NULL
antiapoptosis	NULL
by	NULL
linking	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B-signaling	NULL
pathway	NULL
to	NULL
the	NULL
up-regulation	NULL
of	NULL
the	NULL
antiapoptotic	NULL
Bcl-2	NULL
family	NULL
members	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Chemicals	NULL
and	NULL
Antibodies	NULL
.	NULL

Antibodies	NULL
for	NULL
detection	NULL
of	NULL
Bel-x	NULL
(	NULL
se	NULL
634	NULL
)	NULL
and	NULL
for	NULL
use	NULL
in	NULL
supershift	NULL
assays	NULL
were	NULL
obtained	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
the	NULL
anti-c-Rel	NULL
antibody	NULL
,	NULL
which	NULL
was	NULL
obtained	NULL
from	NULL
Nancy	NULL
Rice	NULL
(	NULL
National	NULL
Abbreviations	NULL
:	NULL
IB	NULL
,	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
;	NULL
TNF	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
;	NULL
TRAF	NULL
,	NULL
TNF	NULL
receptor-associated	NULL
factor	NULL
;	NULL
HA	NULL
,	NULL
hemagglutinin	NULL
;	NULL
4-OHT	NULL
,	NULL
4-hydroxytamoxifen	NULL
;	NULL
ER	NULL
,	NULL
estrogen	NULL
receptor	NULL
ligand-binding	NULL
domain	NULL
;	NULL
sIgM	NULL
,	NULL
surface	NULL
IgM	NULL
.	NULL

*H.H.L	NULL
.	NULL

and	NULL
H.D	NULL
.	NULL

contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
.	NULL

*To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

E-mail	NULL
:	NULL
genhongc	NULL
@	NULL
microbio.ucla.edu	NULL
.	NULL

Cell	NULL
Biology	NULL
:	NULL
Lee	NULL
et	NULL
al	NULL
.	NULL

Cancer	NULL
Institute/Frederick	NULL
Cancer	NULL
Research	NULL
and	NULL
Development	NULL
Center	NULL
)	NULL
.	NULL

The	NULL
CH11	NULL
,	NULL
G28.5	NULL
,	NULL
and	NULL
anti-FLAG	NULL
antibodies	NULL
were	NULL
obtained	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
,	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Manassas	NULL
,	NULL
VA	NULL
)	NULL
,	NULL
and	NULL
Babco	NULL
(	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

4-Hydroxytamoxifen	NULL
(	NULL
4-OHT	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Calbiochem	NULL
.	NULL

Plasmid	NULL
Construction	NULL
.	NULL

The	NULL
5'-FLAG-tagged	NULL
IxB	NULL
mutant	NULL
was	NULL
fused	NULL
in-frame	NULL
to	NULL
the	NULL
5	NULL
end	NULL
of	NULL
the	NULL
mutant	NULL
estrogen	NULL
receptor	NULL
ligand-binding	NULL
domain	NULL
(	NULL
ER	NULL
)	NULL
,	NULL
and	NULL
the	NULL
chimera	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
HindIlII/EcoRI	NULL
sites	NULL
of	NULL
pCDNA3	NULL
to	NULL
generate	NULL
the	NULL
pCDNA3-IxBm-ER	NULL
construct	NULL
.	NULL

The	NULL
pEBB-puro-Bel-x-HA	NULL
construct	NULL
was	NULL
generated	NULL
by	NULL
PCR	NULL
cloning	NULL
of	NULL
human	NULL
Bel-x	NULL
,	NULL
which	NULL
then	NULL
was	NULL
inserted	NULL
into	NULL
the	NULL
BamHI	NULL
and	NULL
NotI	NULL
sites	NULL
of	NULL
pEBB-puro-HA	NULL
in-frame	NULL
with	NULL
the	NULL
3	NULL
'	NULL
influenza	NULL
hemagglutinin	NULL
(	NULL
HA	NULL
)	NULL
tag	NULL
.	NULL

For	NULL
luciferase	NULL
assays	NULL
,	NULL
a	NULL
650-bp	NULL
region	NULL
of	NULL
the	NULL
Bcl-x	NULL
pro-moter	NULL
,	NULL
spanning	NULL
-640	NULL
to	NULL
+9	NULL
relative	NULL
to	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
,	NULL
was	NULL
inserted	NULL
between	NULL
the	NULL
Xhol	NULL
and	NULL
HindIII	NULL
sites	NULL
of	NULL
the	NULL
pGL2-Basic	NULL
luciferase	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
NF-KB	NULL
mutant	NULL
promoter	NULL
had	NULL
an	NULL
internal	NULL
deletion	NULL
spanning	NULL
the	NULL
two	NULL
potential	NULL
NF-	NULL
«	NULL
B	NULL
cis	NULL
elements	NULL
from	NULL
-84	NULL
to	NULL
-46	NULL
relative	NULL
to	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
.	NULL

Cell	NULL
Culture	NULL
and	NULL
Transfection	NULL
.	NULL

Cell	NULL
lines	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FBS	NULL
and	NULL
1	NULL
%	NULL
penicillin/streptomycin	NULL
.	NULL

For	NULL
electroporations	NULL
,	NULL
cells	NULL
were	NULL
pulsed	NULL
at	NULL
250	NULL
V/975	NULL
uF	NULL
and	NULL
then	NULL
selected	NULL
and	NULL
maintained	NULL
in	NULL
1	NULL
mg/ml	NULL
active	NULL
G418	NULL
(	NULL
Mediatech	NULL
,	NULL
Washington	NULL
,	NULL
DC	NULL
)	NULL
or	NULL
in	NULL
2.5	NULL
ug/ml	NULL
puromycin	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

293T	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
DMEM	NULL
(	NULL
GIBCO/BRL	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FBS	NULL
and	NULL
were	NULL
transfected	NULL
by	NULL
using	NULL
standard	NULL
calcium	NULL
phosphate	NULL
methods	NULL
.	NULL

Representational	NULL
Difference	NULL
Analysis	NULL
.	NULL

Two	NULL
identical	NULL
cultures	NULL
of	NULL
20	NULL
X	NULL
10°	NULL
Daudi	NULL
cells	NULL
at	NULL
a	NULL
density	NULL
of	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
were	NULL
incubated	NULL
for	NULL
14	NULL
hr	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
G28.5	NULL
at	NULL
1	NULL
ug/ml	NULL
.	NULL

Poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
whole	NULL
cells	NULL
by	NULL
using	NULL
a	NULL
commercial	NULL
mRNA	NULL
isolation	NULL
kit	NULL
(	NULL
Pharmacia	NULL
)	NULL
,	NULL
and	NULL
cDNA	NULL
was	NULL
generated	NULL
by	NULL
using	NULL
Superscript	NULL
reverse	NULL
transcrip-tase	NULL
(	NULL
GIBCO	NULL
)	NULL
.	NULL

Representational	NULL
difference	NULL
analysis	NULL
was	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

Two	NULL
rounds	NULL
of	NULL
hybridization-PCR	NULL
amplification	NULL
were	NULL
performed	NULL
,	NULL
and	NULL
the	NULL
products	NULL
of	NULL
the	NULL
second	NULL
round	NULL
of	NULL
subtraction	NULL
were	NULL
cloned	NULL
into	NULL
pSKII	NULL
Bluescript	NULL
(	NULL
Stratagene	NULL
)	NULL
for	NULL
sequencing	NULL
.	NULL

Electrophoretic	NULL
Mobility-Shift	NULL
Assays	NULL
.	NULL

For	NULL
gel-shift	NULL
assays	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
text	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
used	NULL
in	NULL
binding	NULL
reactions	NULL
with	NULL
either	NULL
a	NULL
y-	NULL
``	NULL
°P-labeled	NULL
MHC	NULL
II	NULL
NF-	NULL
«	NULL
B-specific	NULL
hairpin	NULL
oligonucleotide	NULL
(	NULL
23	NULL
)	NULL
or	NULL
with	NULL
a	NULL
-labeled	NULL
annealed	NULL
sense	NULL
and	NULL
antisense	NULL
oligonucleotide	NULL
encoding	NULL
the	NULL
Bcl-x	NULL
promoter	NULL
from	NULL
-84	NULL
to	NULL
-46	NULL
by	NULL
using	NULL
previously	NULL
published	NULL
protocols	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
sense	NULL
strand	NULL
of	NULL
the	NULL
Bel-x	NULL
probe	NULL
is	NULL
GGCGGGGGGGACTGC-CCAGGGAGTGACTTTCCGAGGAAG	NULL
.	NULL

For	NULL
supershifts	NULL
,	NULL
1	NULL
pl	NULL
of	NULL
the	NULL
appropriate	NULL
antibody	NULL
was	NULL
added	NULL
to	NULL
the	NULL
nuclear	NULL
extracts	NULL
for	NULL
20	NULL
min	NULL
on	NULL
ice	NULL
before	NULL
addition	NULL
of	NULL
the	NULL
radiolabeled	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

Laddering	NULL
Assay	NULL
.	NULL

For	NULL
DNA	NULL
laddering	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
in	NULL
5	NULL
ml	NULL
of	NULL
medium	NULL
for	NULL
24	NULL
hr	NULL
with	NULL
the	NULL
appropriate	NULL
stimuli	NULL
before	NULL
processing	NULL
the	NULL
samples	NULL
by	NULL
using	NULL
previously	NULL
published	NULL
protocols	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Fluorescence-Activated	NULL
Cell	NULL
Sorter	NULL
(	NULL
FACS	NULL
)	NULL
Analysis	NULL
.	NULL

Cells	NULL
were	NULL
stained	NULL
with	NULL
a	NULL
hypotonic	NULL
propidium	NULL
iodide	NULL
solution	NULL
(	NULL
3.4	NULL
mM	NULL
sodium	NULL
citrate/0.3	NULL
%	NULL
Triton	NULL
X-100/0.1	NULL
mg/ml	NULL
propidium	NULL
iodide/20	NULL
ug/ml	NULL
of	NULL
ribonuclease	NULL
A	NULL
)	NULL
and	NULL
used	NULL
immediately	NULL
for	NULL
cell	NULL
cycle	NULL
analysis	NULL
on	NULL
a	NULL
FACScan	NULL
flow	NULL
cytometer	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

RESULTS	NULL
Identification	NULL
of	NULL
Bfl-1	NULL
as	NULL
a	NULL
CD40-Induced	NULL
Gene	NULL
in	NULL
Human	NULL
B	NULL
Cells	NULL
.	NULL

CD40	NULL
signaling	NULL
is	NULL
believed	NULL
to	NULL
activate	NULL
a	NULL
number	NULL
of	NULL
downstream	NULL
pathways	NULL
,	NULL
which	NULL
lead	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
specific	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
the	NULL
SAPK/JNK	NULL
pathway	NULL
,	NULL
the	NULL
p38	NULL
kinase	NULL
pathway	NULL
,	NULL
the	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
(	NULL
1999	NULL
)	NULL
9137	NULL
(	NULL
ERK	NULL
)	NULL
pathway	NULL
,	NULL
and	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
pathway	NULL
.	NULL

To	NULL
identify	NULL
target	NULL
effector	NULL
genes	NULL
that	NULL
mediate	NULL
the	NULL
complex	NULL
biological	NULL
responses	NULL
of	NULL
CD40	NULL
activation	NULL
,	NULL
representational	NULL
difference	NULL
analysis	NULL
was	NULL
undertaken	NULL
.	NULL

Daudi	NULL
cells	NULL
,	NULL
a	NULL
human	NULL
B	NULL
cell	NULL
lymphoma	NULL
line	NULL
,	NULL
were	NULL
either	NULL
stimulated	NULL
for	NULL
14	NULL
hr	NULL
with	NULL
the	NULL
anti-human	NULL
CD40	NULL
antibody	NULL
,	NULL
G28.5	NULL
,	NULL
or	NULL
cultured	NULL
under	NULL
identical	NULL
conditions	NULL
without	NULL
stimulation	NULL
.	NULL

Using	NULL
cDNA	NULL
isolated	NULL
from	NULL
both	NULL
pools	NULL
of	NULL
cells	NULL
,	NULL
screening	NULL
was	NULL
performed	NULL
through	NULL
two	NULL
rounds	NULL
of	NULL
hybridization-PCR	NULL
amplification	NULL
,	NULL
after	NULL
which	NULL
the	NULL
subtracted	NULL
products	NULL
representing	NULL
CD4O0-induced	NULL
genes	NULL
were	NULL
subcloned	NULL
for	NULL
sequencing	NULL
.	NULL

Among	NULL
the	NULL
genes	NULL
identified	NULL
were	NULL
a	NULL
number	NULL
of	NULL
known	NULL
CD40-inducible	NULL
molecules	NULL
such	NULL
as	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
and	NULL
various	NULL
class	NULL
II	NULL
MHC	NULL
chains	NULL
.	NULL

Through	NULL
this	NULL
process	NULL
,	NULL
we	NULL
identified	NULL
a	NULL
protein	NULL
known	NULL
as	NULL
Bfl-1/A1/GRS	NULL
.	NULL

Bfl-1	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
Bcl-2	NULL
family	NULL
of	NULL
apoptosis-regulatory	NULL
proteins	NULL
,	NULL
which	NULL
are	NULL
expressed	NULL
in	NULL
various	NULL
tissues	NULL
during	NULL
development	NULL
and	NULL
adult	NULL
life	NULL
.	NULL

It	NULL
was	NULL
reported	NULL
to	NULL
be	NULL
overexpressed	NULL
in	NULL
a	NULL
number	NULL
of	NULL
cancer	NULL
cell	NULL
lines	NULL
(	NULL
26	NULL
)	NULL
and	NULL
was	NULL
shown	NULL
to	NULL
protect	NULL
cells	NULL
from	NULL
apoptosis	NULL
and	NULL
cooperate	NULL
with	NULL
the	NULL
adenoviral	NULL
E1A	NULL
protein	NULL
to	NULL
transform	NULL
cells	NULL
in	NULL
culture	NULL
(	NULL
27	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
Bfl-1	NULL
,	NULL
our	NULL
screen	NULL
isolated	NULL
another	NULL
Bcl-2	NULL
family	NULL
member	NULL
,	NULL
Bcl-x	NULL
,	NULL
which	NULL
has	NULL
been	NULL
characterized	NULL
previously	NULL
as	NULL
an	NULL
antiapoptotic	NULL
molecule	NULL
induced	NULL
by	NULL
CD40	NULL
.	NULL

To	NULL
confirm	NULL
the	NULL
induction	NULL
of	NULL
Bfl-1	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
we	NULL
probed	NULL
Northern	NULL
blots	NULL
containing	NULL
RNA	NULL
from	NULL
three	NULL
human	NULL
B	NULL
cell	NULL
lines	NULL
:	NULL
Daudi	NULL
,	NULL
Ramos	NULL
,	NULL
and	NULL
BJAB	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

In	NULL
all	NULL
three	NULL
cell	NULL
lines	NULL
,	NULL
there	NULL
is	NULL
a	NULL
dramatic	NULL
increase	NULL
in	NULL
Bfl-1	NULL
RNA	NULL
after	NULL
16	NULL
hr	NULL
of	NULL
CD40	NULL
stimulation	NULL
.	NULL

Thus	NULL
,	NULL
Bfl-1	NULL
expression	NULL
,	NULL
like	NULL
that	NULL
of	NULL
Bcl-x	NULL
,	NULL
appears	NULL
to	NULL
respond	NULL
strongly	NULL
to	NULL
CD40	NULL
stimulation	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Rapid	NULL
and	NULL
Transient	NULL
CD4O0-Mediated	NULL
Induction	NULL
of	NULL
Bfl-1	NULL
and	NULL
Bcl-x	NULL
Occurs	NULL
Independently	NULL
of	NULL
New	NULL
Protein	NULL
Synthesis	NULL
.	NULL

Because	NULL
the	NULL
activation	NULL
of	NULL
apoptosis	NULL
occurs	NULL
rapidly	NULL
through	NULL
the	NULL
processing	NULL
of	NULL
preformed	NULL
components	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
antiapoptotic	NULL
molecules	NULL
by	NULL
CD40	NULL
also	NULL
must	NULL
be	NULL
rapid	NULL
to	NULL
be	NULL
effective	NULL
.	NULL

We	NULL
investigated	NULL
the	NULL
temporal	NULL
regulation	NULL
of	NULL
Bcl-x	NULL
and	NULL
Bfl-1	NULL
in	NULL
CD4O0-stimulated	NULL
Daudi	NULL
cells	NULL
by	NULL
analyzing	NULL
RNA	NULL
samples	NULL
collected	NULL
at	NULL
various	NULL
time	NULL
points	NULL
after	NULL
stimulation	NULL
with	NULL
G28.5	NULL
.	NULL

The	NULL
A	NULL
Daudi	NULL
Ramos	NULL
BJAB	NULL
anti-CD40	NULL
-	NULL
¢	NULL
-__	NULL
+	NULL
Bfi-1	NULL
wur	NULL
wes	NULL
«	NULL
waute	NULL
B	NULL
+	NULL
CHX	NULL
hours	NULL
anti-CD40	NULL
o	NULL
4	NULL
8	NULL
16	NULL
24	NULL
36	NULL
0	NULL
4	NULL
8	NULL
16	NULL
Bfl-1	NULL
coe	NULL
m	NULL
mus	NULL
.	NULL

aas	NULL
nn	NULL
Bcl-x	NULL
-	NULL
w.	NULL
dts	NULL
its	NULL
cams	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

-	NULL
Bcl-x	NULL
and	NULL
Bfl-1	NULL
are	NULL
rapidly	NULL
induced	NULL
primary	NULL
response	NULL
genes	NULL
.	NULL

(	NULL
4	NULL
)	NULL
CD40	NULL
inducibility	NULL
of	NULL
Bfl-1	NULL
was	NULL
confirmed	NULL
in	NULL
three	NULL
human	NULL
B	NULL
cell	NULL
lines	NULL
cultured	NULL
for	NULL
16	NULL
hr	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
G28.5	NULL
.	NULL

All	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
1	NULL
ug/ml	NULL
G28.5	NULL
at	NULL
a	NULL
density	NULL
of	NULL
1	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
.	NULL

Eighteen	NULL
micrograms	NULL
of	NULL
total	NULL
RNA	NULL
was	NULL
loaded	NULL
per	NULL
lane	NULL
,	NULL
and	NULL
the	NULL
Northern	NULL
blot	NULL
was	NULL
hybridized	NULL
with	NULL
a	NULL
human	NULL
Bfl-1	NULL
probe	NULL
.	NULL

The	NULL
Northern	NULL
blot	NULL
was	NULL
stripped	NULL
,	NULL
and	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
expression	NULL
was	NULL
probed	NULL
as	NULL
a	NULL
standard	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
kinetics	NULL
of	NULL
Bfl-1	NULL
and	NULL
Bcl-x	NULL
induction	NULL
in	NULL
Daudi	NULL
cells	NULL
were	NULL
determined	NULL
by	NULL
examining	NULL
gene	NULL
expression	NULL
after	NULL
various	NULL
periods	NULL
of	NULL
G28.5	NULL
stimulation	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
requirement	NULL
for	NULL
new	NULL
protein	NULL
synthesis	NULL
in	NULL
the	NULL
CD4O0-mediated	NULL
induction	NULL
of	NULL
these	NULL
genes	NULL
,	NULL
cells	NULL
were	NULL
pretreated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
the	NULL
protein	NULL
synthesis	NULL
inhibitor	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
)	NULL
at	NULL
25	NULL
ug/ml	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
G28.5	NULL
antibody	NULL
for	NULL
various	NULL
periods	NULL
of	NULL
time	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CHX	NULL
.	NULL

All	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
1	NULL
ug/ml	NULL
G28.5	NULL
at	NULL
a	NULL
density	NULL
of	NULL
1	NULL
X	NULL
105	NULL
cells	NULL
per	NULL
ml	NULL
.	NULL

Eighteen	NULL
micrograms	NULL
of	NULL
total	NULL
RNA	NULL
was	NULL
loaded	NULL
per	NULL
lane	NULL
,	NULL
and	NULL
the	NULL
Northern	NULL
blots	NULL
were	NULL
hybridized	NULL
with	NULL
a	NULL
human	NULL
Bfl-1	NULL
or	NULL
Bcl-x	NULL
probe	NULL
.	NULL

Northern	NULL
blots	NULL
were	NULL
stripped	NULL
,	NULL
and	NULL
GAPDH	NULL
expression	NULL
was	NULL
probed	NULL
as	NULL
a	NULL
standard	NULL
.	NULL

9138	NULL
Cell	NULL
Biology	NULL
:	NULL
Lee	NULL
et	NULL
al	NULL
.	NULL

same	NULL
results	NULL
were	NULL
observed	NULL
by	NULL
using	NULL
soluble	NULL
CD40	NULL
ligand	NULL
as	NULL
the	NULL
stimulus	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
both	NULL
molecules	NULL
are	NULL
induced	NULL
rapidly	NULL
by	NULL
CD40	NULL
stimulation	NULL
,	NULL
with	NULL
peak	NULL
expression	NULL
levels	NULL
at	NULL
4-8	NULL
hr	NULL
after	NULL
activation	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
decline	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
both	NULL
transcripts	NULL
at	NULL
later	NULL
time	NULL
points	NULL
.	NULL

At	NULL
the	NULL
protein	NULL
level	NULL
,	NULL
however	NULL
,	NULL
Bel-x	NULL
still	NULL
was	NULL
induced	NULL
strongly	NULL
even	NULL
at	NULL
24	NULL
hr	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
or	NULL
not	NULL
the	NULL
induction	NULL
of	NULL
these	NULL
genes	NULL
requires	NULL
the	NULL
synthesis	NULL
of	NULL
intermediate	NULL
factors	NULL
,	NULL
we	NULL
stimulated	NULL
Daudi	NULL
cells	NULL
for	NULL
different	NULL
time	NULL
periods	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
protein	NULL
synthesis	NULL
inhibitor	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
the	NULL
products	NULL
of	NULL
these	NULL
cells	NULL
revealed	NULL
that	NULL
both	NULL
Bcl-x	NULL
and	NULL
Bfl-1	NULL
transcripts	NULL
continue	NULL
to	NULL
be	NULL
synthesized	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
new	NULL
protein	NULL
synthesis	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
;	NULL
however	NULL
,	NULL
the	NULL
use	NULL
of	NULL
CHX	NULL
affects	NULL
the	NULL
expression	NULL
of	NULL
these	NULL
two	NULL
genes	NULL
in	NULL
different	NULL
ways	NULL
.	NULL

Although	NULL
the	NULL
magnitude	NULL
of	NULL
induction	NULL
of	NULL
Bcl-x	NULL
remains	NULL
the	NULL
same	NULL
,	NULL
the	NULL
response	NULL
of	NULL
Bfl-1	NULL
to	NULL
CD40	NULL
stimulation	NULL
is	NULL
blunted	NULL
,	NULL
suggesting	NULL
that	NULL
full	NULL
induction	NULL
of	NULL
Bfl-1	NULL
requires	NULL
the	NULL
participation	NULL
of	NULL
transcription	NULL
factors	NULL
whose	NULL
activity	NULL
is	NULL
sensitive	NULL
to	NULL
protein	NULL
synthesis	NULL
inhibition	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
regulatory	NULL
mechanisms	NULL
of	NULL
these	NULL
two	NULL
genes	NULL
are	NULL
not	NULL
identical	NULL
,	NULL
but	NULL
they	NULL
have	NULL
in	NULL
common	NULL
a	NULL
rapid	NULL
and	NULL
transient	NULL
induction	NULL
phase	NULL
that	NULL
is	NULL
not	NULL
abolished	NULL
by	NULL
protein	NULL
synthesis	NULL
inhibition	NULL
.	NULL

Establishing	NULL
NF-B-Blocked	NULL
Daudi	NULL
and	NULL
Ramos	NULL
Stable	NULL
Cell	NULL
Lines	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
our	NULL
data	NULL
showing	NULL
the	NULL
up-regulation	NULL
of	NULL
Bfl-1	NULL
and	NULL
Bcl-x	NULL
by	NULL
CD40	NULL
signaling	NULL
,	NULL
Bfl-1	NULL
also	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
induced	NULL
by	NULL
various	NULL
stimuli	NULL
such	NULL
as	NULL
TNF-a	NULL
,	NULL
lipopolysac-charide	NULL
,	NULL
granulocyte/macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
and	NULL
IL-1	NULL
,	NULL
whereas	NULL
Bcl-x	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
up-regulated	NULL
by	NULL
CD40	NULL
and	NULL
sIgM	NULL
signaling	NULL
(	NULL
11	NULL
,	NULL
28-30	NULL
)	NULL
.	NULL

All	NULL
of	NULL
these	NULL
stimuli	NULL
share	NULL
the	NULL
common	NULL
feature	NULL
of	NULL
signaling	NULL
through	NULL
NF-kB	NULL
.	NULL

Because	NULL
of	NULL
Daudi	NULL
Daudi	NULL
amos	NULL
Tiamos	NULL
[	NULL
cen	NULL
tyee	NULL
|	NULL
P	NULL
&	NULL
P	NULL
``	NULL
|__	NULL
wales	NULL
a	NULL
--	NULL
B	NULL
Daudi	NULL
Ramos	NULL
Daudi	NULL
hiB-ER	NULL
Ramos	NULL
hcB-ER	NULL
anti-CD40	NULL
r	NULL
--	NULL
gO	NULL
F°	NULL
!	NULL

.	NULL

m	NULL
l	NULL
aye	NULL
real	NULL
BA-1	NULL
walle	NULL
GAPDH	NULL
coum	NULL
.	NULL

.	NULL

oem	NULL
mee	NULL
.	NULL

cee	NULL
.	NULL

eee	NULL
.	NULL

cen	NULL
.	NULL

cams	NULL
Bcl-x	NULL
=	NULL
fed	NULL
sues	NULL
-	NULL
ats	NULL
.	NULL

(	NULL
Wl	NULL
-	NULL
ms	NULL
-	NULL
o	NULL
GAPDH	NULL
cues	NULL
.	NULL

cme	NULL
.	NULL

meee	NULL
cme	NULL
.	NULL

cmm	NULL
.	NULL

mee	NULL
mme	NULL
C	NULL
Daudi	NULL
Daudi	NULL
hkB-ER	NULL
I	NULL
If	NULL
U	NULL
hours	NULL
anti-co4o	NULL
[	NULL
0	NULL
|	NULL
s	NULL
|16	NULL
|24	NULL
|	NULL
o	NULL
|	NULL
s	NULL
|16	NULL
|	NULL
24	NULL
]	NULL
L	NULL
J	NULL
L	NULL
j	NULL
Ramos	NULL
Ramos	NULL
hB-ER	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

-	NULL
Cells	NULL
expressing	NULL
IxB-ER	NULL
have	NULL
a	NULL
functional	NULL
block	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
signaling	NULL
and	NULL
do	NULL
not	NULL
up-regulate	NULL
Bcl-x	NULL
and	NULL
Bfl-1	NULL
in	NULL
response	NULL
to	NULL
CD40	NULL
activation	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Cells	NULL
were	NULL
stimulated	NULL
for	NULL
25	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
1	NULL
ug/ml	NULL
G28.5	NULL
antibody	NULL
,	NULL
and	NULL
the	NULL
nuclear	NULL
extracts	NULL
were	NULL
then	NULL
processed	NULL
as	NULL
described	NULL
previously	NULL
.	NULL

Six	NULL
micrograms	NULL
of	NULL
nuclear	NULL
extracts	NULL
then	NULL
were	NULL
used	NULL
in	NULL
binding	NULL
assays	NULL
with	NULL
the	NULL
radiolabeled	NULL
MHC	NULL
II	NULL
oligonucleotide	NULL
.	NULL

Cells	NULL
induced	NULL
with	NULL
4-OHT	NULL
were	NULL
pretreated	NULL
with	NULL
200	NULL
nM	NULL
of	NULL
the	NULL
synthetic	NULL
estrogen	NULL
for	NULL
3	NULL
hr	NULL
before	NULL
G28.5-mediated	NULL
activation	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Daudi	NULL
,	NULL
Daudi-IkB-ER	NULL
,	NULL
Ramos	NULL
,	NULL
and	NULL
Ramos-IxB-ER	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
4-OHT	NULL
for	NULL
45	NULL
min	NULL
and	NULL
then	NULL
cultured	NULL
for	NULL
8	NULL
hr	NULL
in	NULL
4-OHT	NULL
alone	NULL
or	NULL
4-0HT	NULL
plus	NULL
G28.5	NULL
.	NULL

Eighteen	NULL
micrograms	NULL
of	NULL
total	NULL
RNA	NULL
was	NULL
loaded	NULL
per	NULL
lane	NULL
,	NULL
and	NULL
the	NULL
Northern	NULL
blots	NULL
were	NULL
hybridized	NULL
with	NULL
a	NULL
human	NULL
Bfl-1	NULL
or	NULL
Bcl-x	NULL
probe	NULL
.	NULL

Northern	NULL
blots	NULL
were	NULL
stripped	NULL
and	NULL
glyceraldehyde	NULL
3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
expression	NULL
was	NULL
probed	NULL
as	NULL
a	NULL
standard	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Daudi	NULL
,	NULL
Daudi-IxB-ER	NULL
,	NULL
Ramos	NULL
,	NULL
and	NULL
Ramos-IkB-ER	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
4-OHT	NULL
for	NULL
2	NULL
hr	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
G28.5	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
4-0HT	NULL
for	NULL
different	NULL
periods	NULL
of	NULL
time	NULL
.	NULL

Total	NULL
cell	NULL
extracts	NULL
from	NULL
1	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
loaded	NULL
per	NULL
lane	NULL
,	NULL
and	NULL
Western	NULL
blotting	NULL
was	NULL
performed	NULL
to	NULL
detect	NULL
Bcl-x	NULL
expression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
(	NULL
1999	NULL
)	NULL
the	NULL
established	NULL
link	NULL
between	NULL
NF-	NULL
«	NULL
B	NULL
signaling	NULL
and	NULL
the	NULL
regulation	NULL
of	NULL
apoptosis	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
determine	NULL
the	NULL
role	NULL
of	NULL
NF-KB	NULL
signaling	NULL
in	NULL
CD40-mediated	NULL
up-regulation	NULL
of	NULL
both	NULL
Bel-2	NULL
family	NULL
members	NULL
.	NULL

To	NULL
determine	NULL
this	NULL
role	NULL
,	NULL
we	NULL
established	NULL
human	NULL
B	NULL
cell	NULL
lines	NULL
with	NULL
a	NULL
functional	NULL
block	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B-signaling	NULL
pathway	NULL
.	NULL

The	NULL
strategy	NULL
involved	NULL
the	NULL
overexpression	NULL
of	NULL
a	NULL
chimeric	NULL
fusion	NULL
protein	NULL
consisting	NULL
of	NULL
a	NULL
dominant-active	NULL
IxB-	NULL
«	NULL
mutant	NULL
(	NULL
with	NULL
serine-to-alanine	NULL
mutations	NULL
at	NULL
positions	NULL
32	NULL
and	NULL
36	NULL
)	NULL
fused	NULL
to	NULL
a	NULL
mutated	NULL
estrogen	NULL
receptor	NULL
ligand-binding	NULL
domain	NULL
(	NULL
ER	NULL
)	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
IxB	NULL
mutant	NULL
is	NULL
incapable	NULL
of	NULL
being	NULL
phosphorylated	NULL
at	NULL
the	NULL
critical	NULL
serine	NULL
residues	NULL
and	NULL
,	NULL
therefore	NULL
,	NULL
is	NULL
not	NULL
targeted	NULL
for	NULL
proteosomal	NULL
degradation	NULL
upon	NULL
activation	NULL
of	NULL
the	NULL
IxB	NULL
kinase	NULL
complex	NULL
.	NULL

The	NULL
fused	NULL
ER	NULL
confers	NULL
inducible	NULL
activation	NULL
of	NULL
the	NULL
gene	NULL
of	NULL
interest	NULL
upon	NULL
exposure	NULL
to	NULL
the	NULL
synthetic	NULL
estrogen	NULL
4-OHT	NULL
.	NULL

The	NULL
FLAG-I	NULL
«	NULL
B-mutant-ER	NULL
construct	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
pCDNA3	NULL
expression	NULL
vector	NULL
and	NULL
stably	NULL
transfected	NULL
into	NULL
Daudi	NULL
and	NULL
Ramos	NULL
cells	NULL
.	NULL

Single	NULL
clones	NULL
were	NULL
isolated	NULL
,	NULL
and	NULL
those	NULL
that	NULL
expressed	NULL
the	NULL
construct	NULL
by	NULL
Western	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
were	NULL
chosen	NULL
for	NULL
further	NULL
characterization	NULL
by	NULL
electrophoretic	NULL
mobility-shift	NULL
assay	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
IxB-ER	NULL
construct	NULL
was	NULL
functioning	NULL
to	NULL
block	NULL
NF-	NULL
«	NULL
B	NULL
signaling	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
either	NULL
untreated	NULL
or	NULL
treated	NULL
with	NULL
the	NULL
human	NULL
CDA4O-activating	NULL
G28.5	NULL
antibody	NULL
were	NULL
assessed	NULL
for	NULL
binding	NULL
activity	NULL
to	NULL
a	NULL
radiolabeled	NULL
MHC	NULL
II	NULL
NF-kB	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
H2	NULL
probe	NULL
)	NULL
through	NULL
electrophoretic	NULL
mobility-shift	NULL
assay	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
parental	NULL
Ramos	NULL
and	NULL
Daudi	NULL
cells	NULL
treated	NULL
with	NULL
the	NULL
G28.5	NULL
antibody	NULL
were	NULL
capable	NULL
of	NULL
generating	NULL
gel-shift	NULL
complexes	NULL
representing	NULL
inducible	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
.	NULL

These	NULL
gel-shift	NULL
complexes	NULL
formed	NULL
just	NULL
as	NULL
strongly	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
4-OHT	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
drug	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
signaling	NULL
.	NULL

In	NULL
stable	NULL
Daudi	NULL
and	NULL
Ramos	NULL
clones	NULL
expressing	NULL
the	NULL
IxB-ER	NULL
construct	NULL
,	NULL
however	NULL
,	NULL
CD40-mediated	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
was	NULL
completely	NULL
abolished	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
4-0OHT	NULL
.	NULL

These	NULL
cell	NULL
lines	NULL
also	NULL
had	NULL
significantly	NULL
decreased	NULL
NF-KB	NULL
induction	NULL
in	NULL
the	NULL
absence	NULL
4-OHT	NULL
,	NULL
indicating	NULL
some	NULL
leakage	NULL
in	NULL
the	NULL
system	NULL
.	NULL

Because	NULL
4-OHT	NULL
treatment	NULL
produced	NULL
maximal	NULL
suppression	NULL
of	NULL
NF-KB	NULL
activity	NULL
,	NULL
all	NULL
subsequent	NULL
experiments	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
4-OHT	NULL
.	NULL

The	NULL
NF-xB	NULL
Pathway	NULL
Is	NULL
Essential	NULL
for	NULL
CD40-Mediated	NULL
Bcl-x	NULL
and	NULL
Bfl-1	NULL
Induction	NULL
.	NULL

Using	NULL
the	NULL
NF-	NULL
«	NULL
B-blocked	NULL
cell	NULL
lines	NULL
described	NULL
above	NULL
,	NULL
we	NULL
examined	NULL
CD40	NULL
regulation	NULL
of	NULL
both	NULL
Bel-x	NULL
and	NULL
Bfl-1	NULL
through	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
4-OHT	NULL
,	NULL
parental	NULL
Daudi	NULL
and	NULL
Ramos	NULL
cells	NULL
,	NULL
as	NULL
well	NULL
as	NULL
Daudi-IxB-ER	NULL
and	NULL
Ramos-IxB-ER	NULL
cells	NULL
,	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
treated	NULL
with	NULL
the	NULL
G28.5	NULL
antibody	NULL
for	NULL
8	NULL
hr	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
induction	NULL
of	NULL
both	NULL
genes	NULL
in	NULL
response	NULL
to	NULL
CD40	NULL
treatment	NULL
was	NULL
abolished	NULL
in	NULL
-treated	NULL
Daudi-IkxB-ER	NULL
and	NULL
Ramos-IxB-ER	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
parental	NULL
Daudi	NULL
and	NULL
Ramos	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
these	NULL
cells	NULL
require	NULL
NF-	NULL
«	NULL
B	NULL
signaling	NULL
to	NULL
induce	NULL
both	NULL
of	NULL
these	NULL
genes	NULL
.	NULL

Expression	NULL
of	NULL
Bel-x	NULL
also	NULL
was	NULL
examined	NULL
at	NULL
the	NULL
protein	NULL
level	NULL
in	NULL
the	NULL
same	NULL
cell	NULL
lines	NULL
stimulated	NULL
through	NULL
CD40	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
4-OHT	NULL
for	NULL
different	NULL
time	NULL
periods	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
above	NULL
results	NULL
,	NULL
Western	NULL
blot	NULL
analysis	NULL
showed	NULL
that	NULL
Bcl-x	NULL
expression	NULL
could	NULL
not	NULL
be	NULL
induced	NULL
by	NULL
CD40	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B-blocked	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

We	NULL
also	NULL
observed	NULL
that	NULL
although	NULL
the	NULL
induction	NULL
of	NULL
Bcl-x	NULL
,	NULL
both	NULL
at	NULL
the	NULL
RNA	NULL
and	NULL
protein	NULL
levels	NULL
,	NULL
was	NULL
completely	NULL
abolished	NULL
in	NULL
IxB-ER	NULL
cells	NULL
,	NULL
its	NULL
basal	NULL
expression	NULL
was	NULL
not	NULL
af-fected	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
other	NULL
transcription	NULL
factors	NULL
may	NULL
be	NULL
able	NULL
to	NULL
substitute	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
baseline	NULL
expression	NULL
of	NULL
this	NULL
gene	NULL
or	NULL
that	NULL
there	NULL
is	NULL
enough	NULL
leak-through	NULL
NF-KB	NULL
activity	NULL
,	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
4-O0HT	NULL
,	NULL
to	NULL
enable	NULL
low-level	NULL
Bel-x	NULL
expression	NULL
.	NULL

An	NULL
Consensus	NULL
Sequence	NULL
in	NULL
the	NULL
Bcl-x	NULL
Promoter	NULL
Binds	NULL
NF-B	NULL
Complexes	NULL
and	NULL
Supports	NULL
Transcriptional	NULL
Activity	NULL
.	NULL

The	NULL
Northern	NULL
and	NULL
Western	NULL
blot	NULL
analyses	NULL
with	NULL
the	NULL
stable	NULL
cell	NULL
lines	NULL
strongly	NULL
support	NULL
the	NULL
role	NULL
of	NULL
NF-kB	NULL
signaling	NULL
in	NULL
CD40-mediated	NULL
up-regulation	NULL
of	NULL
Bfl-1	NULL
and	NULL
Bcl-x	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
these	NULL
results	NULL
,	NULL
visual	NULL
inspection	NULL
of	NULL
the	NULL
human	NULL
Bel-x	NULL
promoter	NULL
Cell	NULL
Biology	NULL
:	NULL
Lee	NULL
et	NULL
al	NULL
.	NULL

identified	NULL
two	NULL
tandem	NULL
,	NULL
potential	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
,	NULL
one	NULL
starting	NULL
at	NULL
position	NULL
-77	NULL
relative	NULL
to	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
,	NULL
with	NULL
the	NULL
sequence	NULL
GGGACTGCCC	NULL
,	NULL
and	NULL
the	NULL
other	NULL
starting	NULL
at	NULL
position	NULL
-62	NULL
,	NULL
with	NULL
the	NULL
sequence	NULL
GTGACTTTCC	NULL
.	NULL

A	NULL
radiolabeled	NULL
oligonucleotide	NULL
spanning	NULL
the	NULL
two	NULL
potential	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
was	NULL
used	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
and	NULL
G28.5-stimulated	NULL
Daudi	NULL
cells	NULL
to	NULL
assess	NULL
binding	NULL
by	NULL
electrophoretic	NULL
mobility-shift	NULL
assay	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
parental	NULL
Daudi	NULL
cells	NULL
stimulated	NULL
with	NULL
the	NULL
G28.5	NULL
antibody	NULL
were	NULL
capable	NULL
of	NULL
generating	NULL
several	NULL
band	NULL
shifts	NULL
,	NULL
probably	NULL
corresponding	NULL
to	NULL
the	NULL
different	NULL
NF-	NULL
«	NULL
B	NULL
dimer	NULL
complexes	NULL
bound	NULL
to	NULL
the	NULL
probe	NULL
;	NULL
however	NULL
,	NULL
extracts	NULL
from	NULL
stable	NULL
cell	NULL
lines	NULL
expressing	NULL
the	NULL
I	NULL
«	NULL
kB-ER	NULL
construct	NULL
did	NULL
not	NULL
produce	NULL
an	NULL
inducible	NULL
shift	NULL
,	NULL
indicating	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
is	NULL
necessary	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
Bcl-x	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
upon	NULL
CD40	NULL
activation	NULL
.	NULL

Super-shifted	NULL
bands	NULL
were	NULL
detected	NULL
with	NULL
the	NULL
anti-p50	NULL
,	NULL
anti-p65	NULL
,	NULL
and	NULL
anti-c-Rel	NULL
antibodies	NULL
,	NULL
but	NULL
only	NULL
weakly	NULL
,	NULL
if	NULL
at	NULL
all	NULL
,	NULL
with	NULL
the	NULL
other	NULL
anti-Rel	NULL
antibodies	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
gel-shift	NULL
complexes	NULL
consisted	NULL
predominantly	NULL
of	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
c-Rel	NULL
.	NULL

Further	NULL
gel-shift	NULL
analysis	NULL
indicated	NULL
stronger	NULL
NF-kB	NULL
binding	NULL
to	NULL
the	NULL
upstream	NULL
site	NULL
spanning	NULL
positions	NULL
-77	NULL
to	NULL
-68	NULL
than	NULL
to	NULL
the	NULL
downstream	NULL
site	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Luciferase	NULL
reporter	NULL
assays	NULL
also	NULL
were	NULL
performed	NULL
to	NULL
assess	NULL
the	NULL
ability	NULL
of	NULL
Rel	NULL
family	NULL
members	NULL
to	NULL
drive	NULL
transcription	NULL
from	NULL
the	NULL
Bcl-x	NULL
promoter	NULL
.	NULL

A	NULL
650-bp	NULL
DNA	NULL
fragment	NULL
spanning	NULL
the	NULL
Bcl-x	NULL
5-prime	NULL
promoter	NULL
region	NULL
was	NULL
inserted	NULL
into	NULL
the	NULL
pGL2-Basic	NULL
luciferase	NULL
vector	NULL
(	NULL
Bel-x	NULL
WT	NULL
)	NULL
.	NULL

Another	NULL
reporter	NULL
with	NULL
an	NULL
internal	NULL
deletion	NULL
spanning	NULL
the	NULL
potential	NULL
NF-	NULL
«	NULL
B-binding	NULL
region	NULL
(	NULL
Bcl-x	NULL
«	NULL
B-	NULL
)	NULL
also	NULL
was	NULL
created	NULL
.	NULL

293T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
reporters	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
and	NULL
p6S5-expressing	NULL
DNA	NULL
vector	NULL
or	NULL
control	NULL
vector	NULL
DNA	NULL
.	NULL

Cotransfection	NULL
with	NULL
p65	NULL
up-regulated	NULL
reporter	NULL
activity	NULL
from	NULL
the	NULL
Bel-x	NULL
WT	NULL
promoter	NULL
by	NULL
22.3-fold	NULL
(	NULL
SD	NULL
=	NULL
3.1	NULL
)	NULL
relative	NULL
to	NULL
the	NULL
control-transfected	NULL
sam	NULL
A	NULL
E	NULL
&	NULL
anti-NF	NULL
8B	NULL
$	NULL
supershift	NULL
a	NULL
%	NULL
3	NULL
antibody	NULL
E	NULL
s	NULL
€	NULL
&	NULL
i|	NULL
$	NULL
|a|s	NULL
]	NULL
|i\a	NULL
het	NULL
NFB	NULL
l	NULL
i	NULL
l	NULL
complexes	NULL
cas	NULL
|-	NULL
[	NULL
+	NULL
[	NULL
]	NULL
-|	NULL
+	NULL
[	NULL
+	NULL
[	NULL
+1+	NULL
[	NULL
+	NULL
[	NULL
+	NULL
[	NULL
+I-|+	NULL
Cell	NULL
Line	NULL
Parental	NULL
Daudi	NULL
|	NULL
heB-E	NULL
R	NULL
Probe	NULL
|	NULL
M2	NULL
,	NULL
Bcl-x	NULL
NFB	NULL
Probe	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Rel	NULL
members	NULL
are	NULL
capable	NULL
of	NULL
mediating	NULL
transcriptional	NULL
activation	NULL
through	NULL
the	NULL
Bcl-x	NULL
promoter	NULL
by	NULL
binding	NULL
to	NULL
NF-kB	NULL
cis	NULL
elements	NULL
.	NULL

(	NULL
4	NULL
)	NULL
The	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
binding	NULL
to	NULL
the	NULL
putative	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
within	NULL
the	NULL
Bcl-x	NULL
promoter	NULL
consists	NULL
predominantly	NULL
of	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
c-Rel	NULL
.	NULL

Nuclear	NULL
extract	NULL
harvests	NULL
and	NULL
binding	NULL
reactions	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
.	NULL

Supershifts	NULL
were	NULL
performed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
appropriate	NULL
antibody	NULL
to	NULL
the	NULL
nuclear	NULL
extracts	NULL
on	NULL
ice	NULL
20	NULL
min	NULL
before	NULL
the	NULL
binding	NULL
reaction	NULL
.	NULL

(	NULL
B	NULL
)	NULL
p65	NULL
is	NULL
capable	NULL
of	NULL
mediating	NULL
transcriptional	NULL
activation	NULL
through	NULL
the	NULL
Bcl-x	NULL
promoter	NULL
.	NULL

A	NULL
Bcl-x	NULL
promoter	NULL
fragment	NULL
spanning	NULL
-640	NULL
to	NULL
+9	NULL
relative	NULL
to	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
(	NULL
Bcl-x	NULL
WT	NULL
promoter	NULL
)	NULL
and	NULL
another	NULL
fragment	NULL
missing	NULL
the	NULL
NF-	NULL
«	NULL
B-binding	NULL
sequence	NULL
(	NULL
Bcl-x	NULL
«	NULL
B-	NULL
promoter	NULL
)	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
pGL2-Basic	NULL
luciferase	NULL
reporter	NULL
vector	NULL
.	NULL

293T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
100	NULL
ng	NULL
of	NULL
the	NULL
indicated	NULL
reporter	NULL
plasmids	NULL
and	NULL
either	NULL
2	NULL
ug	NULL
of	NULL
p65	NULL
/RelA	NULL
expression	NULL
vector	NULL
or	NULL
2	NULL
ug	NULL
of	NULL
pBABE-puro	NULL
control	NULL
vector	NULL
as	NULL
carrier	NULL
.	NULL

Samples	NULL
were	NULL
harvested	NULL
36	NULL
hr	NULL
after	NULL
transfection	NULL
and	NULL
assessed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
(	NULL
1999	NULL
)	NULL
9139	NULL
ples	NULL
,	NULL
whereas	NULL
p65	NULL
cotransfection	NULL
up-regulated	NULL
reporter	NULL
activity	NULL
by	NULL
only	NULL
2.6-fold	NULL
(	NULL
SD	NULL
=	NULL
0.36	NULL
)	NULL
from	NULL
the	NULL
Bel-x	NULL
«	NULL
B-	NULL
reporter	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
observed	NULL
in	NULL
transiently	NULL
transfected	NULL
Jurkat	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
suggest	NULL
that	NULL
Rel	NULL
members	NULL
are	NULL
capable	NULL
of	NULL
directly	NULL
activating	NULL
transcription	NULL
from	NULL
the	NULL
Bel-x	NULL
promoter	NULL
.	NULL

Activity	NULL
Is	NULL
Required	NULL
for	NULL
Protection	NULL
of	NULL
B	NULL
Cells	NULL
from	NULL
Fas-Mediated	NULL
Apoptosis	NULL
.	NULL

To	NULL
study	NULL
the	NULL
role	NULL
of	NULL
NF-KB	NULL
signaling	NULL
in	NULL
CD4O0-mediated	NULL
rescue	NULL
from	NULL
cell	NULL
death	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
pathway	NULL
was	NULL
crucial	NULL
for	NULL
CD4O0-mediated	NULL
inhibition	NULL
of	NULL
Fas-activated	NULL
cell	NULL
death	NULL
.	NULL

Parental	NULL
Ramos	NULL
cells	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
IxB-ER	NULL
stable	NULL
cell	NULL
line	NULL
,	NULL
were	NULL
either	NULL
left	NULL
untreated	NULL
,	NULL
treated	NULL
with	NULL
the	NULL
G28.5	NULL
antibody	NULL
,	NULL
treated	NULL
with	NULL
the	NULL
human	NULL
Fas-activating	NULL
antibody	NULL
,	NULL
CH11	NULL
,	NULL
or	NULL
treated	NULL
with	NULL
both	NULL
G28.5	NULL
and	NULL
CH11	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
24	NULL
hr	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
harvested	NULL
and	NULL
processed	NULL
for	NULL
apoptotic	NULL
markers	NULL
,	NULL
including	NULL
oligonucleo-somal	NULL
DNA	NULL
laddering	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
and	NULL
analysis	NULL
of	NULL
fraction	NULL
by	NULL
propidium	NULL
iodide	NULL
staining	NULL
and	NULL
FACScan	NULL
cell	NULL
cycle	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Wild-type	NULL
Ramos	NULL
cells	NULL
treated	NULL
with	NULL
the	NULL
CH11	NULL
antibody	NULL
display	NULL
the	NULL
characteristic	NULL
laddering	NULL
profile	NULL
of	NULL
apoptotic	NULL
cells	NULL
and	NULL
also	NULL
had	NULL
a	NULL
high	NULL
fraction	NULL
(	NULL
15.3	NULL
%	NULL
)	NULL
.	NULL

This	NULL
profile	NULL
is	NULL
inhibited	NULL
upon	NULL
CD40	NULL
activation	NULL
,	NULL
which	NULL
reduces	NULL
the	NULL
sub-G4	NULL
fraction	NULL
to	NULL
1.9	NULL
%	NULL
and	NULL
decreases	NULL
the	NULL
amount	NULL
of	NULL
DNA	NULL
laddering	NULL
.	NULL

In	NULL
the	NULL
Ramos	NULL
IkB-ER	NULL
cells	NULL
,	NULL
the	NULL
laddering	NULL
and	NULL
the	NULL
increased	NULL
sub-G	NULL
;	NULL
fraction	NULL
is	NULL
still	NULL
observed	NULL
upon	NULL
treatment	NULL
with	NULL
the	NULL
CH11	NULL
antibody	NULL
,	NULL
but	NULL
cotreatment	NULL
with	NULL
the	NULL
G28.5	NULL
antibody	NULL
does	NULL
not	NULL
inhibit	NULL
the	NULL
laddering	NULL
process	NULL
or	NULL
decrease	NULL
the	NULL
sub-G1	NULL
fraction	NULL
,	NULL
indicating	NULL
that	NULL
cell	NULL
death	NULL
is	NULL
not	NULL
rescued	NULL
by	NULL
CD40	NULL
activation	NULL
in	NULL
the	NULL
I	NULL
«	NULL
kB-ER	NULL
cells	NULL
.	NULL

Daudi	NULL
cells	NULL
were	NULL
not	NULL
sensitive	NULL
to	NULL
Fas-mediated	NULL
killing	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
,	NULL
thus	NULL
,	NULL
were	NULL
not	NULL
used	NULL
to	NULL
assess	NULL
CD4O0-mediated	NULL
inhibition	NULL
of	NULL
this	NULL
process	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
in	NULL
Ramos	NULL
cells	NULL
,	NULL
the	NULL
CD4O0-mediated	NULL
inhibition	NULL
of	NULL
Fas-activated	NULL
cell	NULL
death	NULL
requires	NULL
signaling	NULL
through	NULL
the	NULL
NF-	NULL
«	NULL
B-signaling	NULL
pathway	NULL
.	NULL

Expression	NULL
of	NULL
Bcl-x	NULL
at	NULL
Physiologically	NULL
Induced	NULL
Levels	NULL
Is	NULL
Capable	NULL
of	NULL
Protecting	NULL
Against	NULL
Fas-Mediated	NULL
Cell	NULL
Death	NULL
in	NULL
the	NULL
Absence	NULL
of	NULL
NF-xB	NULL
Activity	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
the	NULL
previous	NULL
sections	NULL
,	NULL
CD40-mediated	NULL
rescue	NULL
of	NULL
Fas-induced	NULL
apoptosis	NULL
proceeds	NULL
through	NULL
an	NULL
NF-	NULL
«	NULL
B-dependent	NULL
pathway	NULL
that	NULL
may	NULL
involve	NULL
the	NULL
up-regulation	NULL
of	NULL
Bel-x	NULL
and	NULL
Bfl-1	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
contribution	NULL
of	NULL
Bel-x	NULL
to	NULL
CD40-mediated	NULL
antiapoptosis	NULL
,	NULL
we	NULL
introduced	NULL
exogenous	NULL
HA-tagged	NULL
Bel-x	NULL
into	NULL
the	NULL
Ramos	NULL
I	NULL
«	NULL
B-ER	NULL
cells	NULL
and	NULL
A	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
$	NULL
Cell	NULL
Line	NULL
G28.5	NULL
CH11	NULL
B	NULL
as	NULL
|	NULL
=	NULL
=	NULL
Percentage	NULL
Sub-G1	NULL
a	NULL
o	NULL
i	NULL
102	NULL
3	NULL
4	NULL
§	NULL
06	NULL
70	NULL
%	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

-	NULL
CD4O0-mediated	NULL
rescue	NULL
of	NULL
Fas-induced	NULL
apoptosis	NULL
is	NULL
ablated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
signaling	NULL
.	NULL

Cells	NULL
(	NULL
6	NULL
x	NULL
10°	NULL
)	NULL
in	NULL
5	NULL
ml	NULL
of	NULL
medium	NULL
were	NULL
either	NULL
untreated	NULL
or	NULL
treated	NULL
for	NULL
24	NULL
hr	NULL
with	NULL
1	NULL
ug/ml	NULL
G28.5	NULL
,	NULL
500	NULL
ng/ml	NULL
CH11	NULL
Fas-activating	NULL
antibody	NULL
,	NULL
or	NULL
both	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
,	NULL
and	NULL
DNA	NULL
fragmentation	NULL
(	NULL
4	NULL
)	NULL
and	NULL
the	NULL
sub-G	NULL
fraction	NULL
(	NULL
B	NULL
)	NULL
were	NULL
assayed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

9140	NULL
Cell	NULL
Biology	NULL
:	NULL
Lee	NULL
et	NULL
al	NULL
.	NULL

then	NULL
determined	NULL
the	NULL
sensitivity	NULL
of	NULL
individual	NULL
clones	NULL
to	NULL
Fas-mediated	NULL
cell	NULL
death	NULL
.	NULL

The	NULL
HA-tagged	NULL
Bel-x	NULL
protein	NULL
migrates	NULL
slightly	NULL
slower	NULL
than	NULL
the	NULL
endogenous	NULL
Bcl-x	NULL
,	NULL
allowing	NULL
for	NULL
comparative	NULL
analysis	NULL
of	NULL
expression	NULL
levels	NULL
in	NULL
the	NULL
isolated	NULL
clones	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
.	NULL

Ramos	NULL
IxB-ER-Bel-x	NULL
clone	NULL
A	NULL
expresses	NULL
exogenous	NULL
Bcl-x	NULL
at	NULL
levels	NULL
similar	NULL
to	NULL
those	NULL
seen	NULL
in	NULL
parental	NULL
Ramos	NULL
cells	NULL
after	NULL
8-16	NULL
hr	NULL
of	NULL
CD40	NULL
stimulation	NULL
.	NULL

Ramos	NULL
I	NULL
«	NULL
B-ER-Bcl-x	NULL
clone	NULL
B	NULL
,	NULL
however	NULL
,	NULL
expresses	NULL
exogenous	NULL
Bel-x	NULL
at	NULL
relatively	NULL
lower	NULL
levels	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
protection	NULL
afforded	NULL
by	NULL
Bcl-x	NULL
against	NULL
Fas-mediated	NULL
death	NULL
,	NULL
parental	NULL
Ramos	NULL
cells	NULL
,	NULL
Ramos	NULL
IxB-ER	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
two	NULL
Bel-x-expressing	NULL
IxB-ER	NULL
cell	NULL
lines	NULL
were	NULL
stimulated	NULL
with	NULL
the	NULL
human	NULL
Fas-activating	NULL
CH11	NULL
antibody	NULL
for	NULL
24	NULL
hr	NULL
,	NULL
and	NULL
cell	NULL
death	NULL
was	NULL
assessed	NULL
by	NULL
DNA	NULL
laddering	NULL
and	NULL
propidium	NULL
iodide	NULL
staining	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
B	NULL
and	NULL
C	NULL
,	NULL
apoptosis	NULL
was	NULL
induced	NULL
in	NULL
both	NULL
the	NULL
parental	NULL
Ramos	NULL
and	NULL
Ramos	NULL
IxB-ER	NULL
cell	NULL
lines	NULL
after	NULL
treatment	NULL
with	NULL
the	NULL
CH11	NULL
antibody	NULL
.	NULL

Ramos	NULL
IxB-ER-Bcel-x	NULL
clone	NULL
A	NULL
,	NULL
which	NULL
expresses	NULL
exogenous	NULL
Bcl-x	NULL
near	NULL
physiologically	NULL
induced	NULL
levels	NULL
,	NULL
is	NULL
resistant	NULL
to	NULL
Fas-mediated	NULL
cell	NULL
death	NULL
,	NULL
whereas	NULL
the	NULL
lower-expressing	NULL
Ramos	NULL
IxB-ER-Bcl-x	NULL
clone	NULL
B	NULL
was	NULL
still	NULL
sensitive	NULL
to	NULL
Fas-mediated	NULL
apoptosis	NULL
.	NULL

Other	NULL
clones	NULL
,	NULL
which	NULL
expressed	NULL
exogenous	NULL
Bcl-x	NULL
at	NULL
levels	NULL
between	NULL
those	NULL
seen	NULL
in	NULL
clones	NULL
A	NULL
and	NULL
B	NULL
,	NULL
likewise	NULL
were	NULL
protected	NULL
at	NULL
intermediary	NULL
levels	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
levels	NULL
of	NULL
Bcl-x	NULL
that	NULL
are	NULL
induced	NULL
by	NULL
CD40	NULL
activation	NULL
are	NULL
sufficient	NULL
for	NULL
mediating	NULL
its	NULL
antiapoptotic	NULL
effects	NULL
against	NULL
Fas	NULL
activation	NULL
.	NULL

A	NULL
G28.5	NULL
stimulation	NULL
(	NULL
hours	NULL
)	NULL
0	NULL
4	NULL
8	NULL
16	NULL
24	NULL
HABctx	NULL
~-	NULL
w-	NULL
comas	NULL
cmm	NULL
sez	NULL
Endogenous	NULL
Bel-10m	NULL
i	NULL
m	NULL
a_	NULL
A	NULL
Parental	NULL
Ramos	NULL
Ramos	NULL
Ramos	NULL
Ram	NULL
Cell	NULL
Ramos	NULL
hef-ER	NULL
hi8-ER	NULL
Line	NULL
|	NULL
``	NULL
``	NULL
*	NULL
BER	NULL
|	NULL
Bax	NULL
-	NULL
Bax	NULL
Clone	NULL
A	NULL
_	NULL
Clone	NULL
B	NULL
en	NULL
-	NULL
]	NULL
+	NULL
C	NULL
®	NULL
24.9	NULL
FiG	NULL
.	NULL

5	NULL
.	NULL

Expression	NULL
of	NULL
exogenous	NULL
Bcl-x	NULL
protects	NULL
against	NULL
Fas-mediated	NULL
cell	NULL
death	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Ramos	NULL
IxB-ER	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
with	NULL
a	NULL
pEBB-puro-Bcl-x-HA	NULL
construct	NULL
,	NULL
and	NULL
stable	NULL
clones	NULL
were	NULL
isolated	NULL
by	NULL
limiting	NULL
dilution	NULL
plating	NULL
and	NULL
selection	NULL
with	NULL
puromycin	NULL
.	NULL

Expression	NULL
of	NULL
exogenous	NULL
Bcl-x	NULL
then	NULL
was	NULL
assessed	NULL
by	NULL
Western	NULL
analysis	NULL
and	NULL
compared	NULL
with	NULL
the	NULL
levels	NULL
of	NULL
endogenous	NULL
Bcl-x	NULL
that	NULL
are	NULL
up-regulated	NULL
in	NULL
response	NULL
to	NULL
CD40	NULL
activation	NULL
by	NULL
the	NULL
G28.5	NULL
antibody	NULL
.	NULL

(	NULL
B	NULL
)	NULL
DNA	NULL
fragmentation	NULL
was	NULL
assessed	NULL
in	NULL
parental	NULL
Ramos	NULL
,	NULL
Ramos	NULL
IxB-ER	NULL
,	NULL
and	NULL
Ramos	NULL
IxB-ER-Bcl-x	NULL
clones	NULL
A	NULL
and	NULL
B	NULL
after	NULL
being	NULL
untreated	NULL
or	NULL
treated	NULL
for	NULL
24	NULL
hr	NULL
with	NULL
CH11	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
sub-G	NULL
fraction	NULL
was	NULL
assessed	NULL
by	NULL
FACScan	NULL
analysis	NULL
after	NULL
propidium	NULL
iodide	NULL
staining	NULL
in	NULL
Ramos	NULL
cells	NULL
,	NULL
Ramos	NULL
IxB-ER	NULL
cells	NULL
,	NULL
and	NULL
Ramos	NULL
IxB-ER-Bel-x	NULL
clones	NULL
A	NULL
and	NULL
B	NULL
after	NULL
being	NULL
untreated	NULL
or	NULL
treated	NULL
for	NULL
24	NULL
hr	NULL
with	NULL
the	NULL
CH11	NULL
antibody	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
(	NULL
1999	NULL
)	NULL
DISCUSSION	NULL
In	NULL
addition	NULL
to	NULL
their	NULL
roles	NULL
in	NULL
inflammation	NULL
and	NULL
immunity	NULL
(	NULL
17	NULL
)	NULL
,	NULL
members	NULL
of	NULL
the	NULL
Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
also	NULL
are	NULL
believed	NULL
to	NULL
play	NULL
important	NULL
roles	NULL
in	NULL
preventing	NULL
programmed	NULL
cell	NULL
death	NULL
.	NULL

Enhanced	NULL
cytotoxicity	NULL
in	NULL
response	NULL
to	NULL
TNF	NULL
treatment	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
RelA~'~	NULL
fibroblasts	NULL
and	NULL
macrophages	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cells	NULL
,	NULL
including	NULL
fibroblasts	NULL
,	NULL
fibrosarcoma	NULL
cells	NULL
,	NULL
and	NULL
lymphoma	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
NF-	NULL
«	NULL
B	NULL
signaling	NULL
or	NULL
protein	NULL
synthesis	NULL
has	NULL
been	NULL
blocked	NULL
specifically	NULL
through	NULL
the	NULL
overexpression	NULL
of	NULL
dominant-negative	NULL
pathway	NULL
components	NULL
or	NULL
through	NULL
the	NULL
use	NULL
of	NULL
cycloheximide	NULL
(	NULL
18-20	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
would	NULL
indicate	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
may	NULL
prevent	NULL
cell	NULL
death	NULL
through	NULL
the	NULL
up-regulation	NULL
of	NULL
specific	NULL
gene	NULL
products	NULL
,	NULL
whereas	NULL
apoptosis	NULL
can	NULL
proceed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
new	NULL
protein	NULL
synthesis	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
preformed	NULL
caspase	NULL
cascade	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
rapid	NULL
induction	NULL
kinetics	NULL
characteristic	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
are	NULL
most	NULL
likely	NULL
crucial	NULL
to	NULL
its	NULL
ability	NULL
to	NULL
compete	NULL
with	NULL
the	NULL
transcription-independent	NULL
apoptosis	NULL
pathway	NULL
.	NULL

A	NULL
large	NULL
number	NULL
of	NULL
genes	NULL
,	NULL
including	NULL
many	NULL
inflammatory	NULL
cytokines	NULL
and	NULL
adhesion	NULL
molecules	NULL
,	NULL
are	NULL
regulated	NULL
by	NULL
NF-KB	NULL
(	NULL
32	NULL
)	NULL
,	NULL
but	NULL
the	NULL
mediators	NULL
of	NULL
this	NULL
pathway	NULL
's	NULL
antiapoptotic	NULL
effect	NULL
have	NULL
remained	NULL
a	NULL
mystery	NULL
until	NULL
the	NULL
recent	NULL
identification	NULL
of	NULL
a	NULL
few	NULL
candidate	NULL
molecules	NULL
,	NULL
including	NULL
the	NULL
antiapoptotic	NULL
inhibitor	NULL
of	NULL
apoptosis	NULL
molecules	NULL
1	NULL
and	NULL
2	NULL
(	NULL
c-IAP	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
TRAFs	NULL
1	NULL
and	NULL
2	NULL
,	NULL
IEX-1L	NULL
,	NULL
and	NULL
A20	NULL
(	NULL
33-36	NULL
)	NULL
.	NULL

Although	NULL
members	NULL
of	NULL
the	NULL
IAP	NULL
family	NULL
recently	NULL
have	NULL
been	NULL
suggested	NULL
to	NULL
act	NULL
as	NULL
direct	NULL
inhibitors	NULL
of	NULL
caspases	NULL
,	NULL
their	NULL
mechanisms	NULL
of	NULL
action-and	NULL
certainly	NULL
those	NULL
of	NULL
the	NULL
TRAFs	NULL
,	NULL
A20	NULL
and	NULL
IEX-1L-are	NULL
not	NULL
yet	NULL
clearly	NULL
under-stood	NULL
.	NULL

Here	NULL
we	NULL
report	NULL
the	NULL
identification	NULL
of	NULL
two	NULL
antiapoptotic	NULL
members	NULL
of	NULL
the	NULL
Bel-2	NULL
family	NULL
as	NULL
targets	NULL
of	NULL
NF-KB	NULL
signaling	NULL
.	NULL

We	NULL
find	NULL
Bfl-1	NULL
to	NULL
be	NULL
induced	NULL
by	NULL
CD40	NULL
signaling	NULL
in	NULL
multiple	NULL
B	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Bcl-x	NULL
has	NULL
been	NULL
well	NULL
characterized	NULL
as	NULL
a	NULL
CD40-responsive	NULL
inhibitor	NULL
of	NULL
apoptosis	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
11-13	NULL
)	NULL
.	NULL

Both	NULL
Bcl-x	NULL
and	NULL
Bfl-1	NULL
are	NULL
induced	NULL
rapidly	NULL
by	NULL
CD40	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
via	NULL
an	NULL
NF-	NULL
«	NULL
B-dependent	NULL
signaling	NULL
pathway	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

We	NULL
also	NULL
have	NULL
identified	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
sequence	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
Bel-x	NULL
,	NULL
and	NULL
an	NULL
inducible	NULL
nuclear	NULL
complex	NULL
that	NULL
is	NULL
recognized	NULL
by	NULL
antibodies	NULL
against	NULL
p50/NF-	NULL
«	NULL
B1	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
p65/RelA	NULL
was	NULL
shown	NULL
to	NULL
bind	NULL
this	NULL
sequence	NULL
in	NULL
stimulated	NULL
control	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
-treated	NULL
,	NULL
IxB-ER-expressing	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
luciferase	NULL
reporter	NULL
construct	NULL
driven	NULL
by	NULL
the	NULL
Bcl-x	NULL
upstream	NULL
promoter	NULL
region	NULL
responded	NULL
strongly	NULL
to	NULL
p65	NULL
expression	NULL
;	NULL
however	NULL
,	NULL
this	NULL
response	NULL
was	NULL
inhibited	NULL
by	NULL
the	NULL
removal	NULL
of	NULL
the	NULL
putative	NULL
NF-	NULL
«	NULL
B-binding	NULL
sequence	NULL
from	NULL
the	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
Bcl-x	NULL
promoter	NULL
contains	NULL
an	NULL
element	NULL
that	NULL
binds	NULL
NF-KB	NULL
transcription	NULL
factors	NULL
and	NULL
supports	NULL
transcriptional	NULL
activation	NULL
by	NULL
a	NULL
member	NULL
of	NULL
this	NULL
family	NULL
.	NULL

CD40	NULL
signaling	NULL
increases	NULL
NF-KB	NULL
activity	NULL
and	NULL
is	NULL
known	NULL
to	NULL
play	NULL
instrumental	NULL
roles	NULL
in	NULL
the	NULL
activation	NULL
,	NULL
proliferation	NULL
,	NULL
and	NULL
differentiation	NULL
of	NULL
B	NULL
cells	NULL
(	NULL
3	NULL
,	NULL
37	NULL
)	NULL
.	NULL

Activated	NULL
proliferating	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
undergo	NULL
a	NULL
process	NULL
of	NULL
somatic	NULL
hypermu-tation	NULL
of	NULL
Ig	NULL
variable	NULL
regions	NULL
followed	NULL
by	NULL
antigen-driven	NULL
selection	NULL
of	NULL
high-affinity	NULL
clones	NULL
as	NULL
they	NULL
migrate	NULL
to	NULL
the	NULL
periphery	NULL
of	NULL
the	NULL
germinal	NULL
center	NULL
.	NULL

Low-affinity	NULL
clones	NULL
,	NULL
as	NULL
well	NULL
as	NULL
those	NULL
that	NULL
acquire	NULL
self-reactivity	NULL
through	NULL
the	NULL
mutation	NULL
process	NULL
,	NULL
are	NULL
believed	NULL
to	NULL
be	NULL
removed	NULL
through	NULL
apoptosis	NULL
.	NULL

CD40	NULL
stimulation	NULL
is	NULL
able	NULL
to	NULL
rescue	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
from	NULL
programmed	NULL
cell	NULL
death	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Cross-linking	NULL
of	NULL
Fas	NULL
leads	NULL
to	NULL
B	NULL
cell	NULL
death	NULL
,	NULL
and	NULL
CD40	NULL
signaling	NULL
can	NULL
protect	NULL
against	NULL
this	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
CD40	NULL
also	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
up-regulate	NULL
Fas	NULL
expression	NULL
in	NULL
mature	NULL
B	NULL
cells	NULL
and	NULL
,	NULL
thus	NULL
,	NULL
actually	NULL
sensitize	NULL
them	NULL
to	NULL
Fas-mediated	NULL
killing	NULL
under	NULL
some	NULL
conditions	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
CD40	NULL
activation	NULL
intensifies	NULL
the	NULL
death	NULL
signal	NULL
of	NULL
Fas	NULL
by	NULL
increasing	NULL
Fas	NULL
expression	NULL
while	NULL
,	NULL
at	NULL
the	NULL
same	NULL
time	NULL
,	NULL
protecting	NULL
against	NULL
this	NULL
effect	NULL
through	NULL
the	NULL
induction	NULL
of	NULL
Bel-x	NULL
above	NULL
basal	NULL
levels	NULL
and	NULL
possibly	NULL
through	NULL
the	NULL
expression	NULL
of	NULL
additional	NULL
antiapoptotic	NULL
molecules	NULL
such	NULL
as	NULL
Bfl-1	NULL
.	NULL

This	NULL
protective	NULL
effect	NULL
of	NULL
CD40	NULL
alone	NULL
,	NULL
however	NULL
,	NULL
is	NULL
transient	NULL
in	NULL
Cell	NULL
Biology	NULL
:	NULL
Lee	NULL
et	NULL
al	NULL
.	NULL

nature	NULL
,	NULL
and	NULL
prolonged	NULL
activation	NULL
of	NULL
Fas	NULL
can	NULL
overcome	NULL
it	NULL
,	NULL
unless	NULL
other	NULL
stimuli	NULL
,	NULL
such	NULL
as	NULL
sIgM	NULL
stimulation	NULL
through	NULL
high-affinity	NULL
antigen	NULL
binding	NULL
,	NULL
are	NULL
also	NULL
present	NULL
(	NULL
39	NULL
)	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
our	NULL
data	NULL
demonstrating	NULL
the	NULL
transient	NULL
induction	NULL
of	NULL
Bel-x	NULL
and	NULL
Bfl-1	NULL
at	NULL
the	NULL
RNA	NULL
level	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
a	NULL
blockade	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
pathway	NULL
,	NULL
which	NULL
leads	NULL
to	NULL
a	NULL
loss	NULL
of	NULL
Bel-x	NULL
and	NULL
Bfl-1	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
,	NULL
abolishes	NULL
the	NULL
protective	NULL
effect	NULL
of	NULL
CD40	NULL
against	NULL
Fas-mediated	NULL
apoptosis	NULL
in	NULL
Ramos	NULL
B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

When	NULL
Bcl-x	NULL
is	NULL
reintroduced	NULL
into	NULL
NF-	NULL
«	NULL
B-blocked	NULL
cells	NULL
,	NULL
they	NULL
are	NULL
protected	NULL
against	NULL
the	NULL
apoptotic	NULL
effects	NULL
of	NULL
Fas	NULL
ligation	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
ectopic	NULL
Bel-x	NULL
protein	NULL
required	NULL
for	NULL
this	NULL
protective	NULL
effect	NULL
is	NULL
roughly	NULL
equivalent	NULL
to	NULL
the	NULL
levels	NULL
of	NULL
endogenous	NULL
Bcl-x	NULL
induced	NULL
by	NULL
CD40	NULL
treatment	NULL
in	NULL
cells	NULL
with	NULL
intact	NULL
NF-KB	NULL
signaling	NULL
.	NULL

Together	NULL
with	NULL
the	NULL
data	NULL
discussed	NULL
above	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
NF-	NULL
«	NULL
B-mediated	NULL
induction	NULL
of	NULL
Bel-x	NULL
expression	NULL
is	NULL
sufficient	NULL
for	NULL
the	NULL
ability	NULL
of	NULL
CD40	NULL
to	NULL
protect	NULL
B	NULL
cells	NULL
from	NULL
Fas-mediated	NULL
apoptosis	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
induce	NULL
antiapoptotic	NULL
proteins	NULL
is	NULL
consistent	NULL
with	NULL
its	NULL
cytoprotective	NULL
nature	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
level	NULL
of	NULL
Bcl-x	NULL
expression	NULL
capable	NULL
of	NULL
protecting	NULL
against	NULL
Fas-mediated	NULL
killing	NULL
represents	NULL
an	NULL
induction	NULL
of	NULL
only	NULL
a	NULL
few	NULL
fold	NULL
above	NULL
baseline	NULL
,	NULL
emphasizing	NULL
the	NULL
quantitatively	NULL
fine	NULL
nature	NULL
of	NULL
this	NULL
balance	NULL
.	NULL

Because	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
pathway	NULL
must	NULL
act	NULL
rapidly	NULL
to	NULL
counteract	NULL
the	NULL
amplification	NULL
of	NULL
the	NULL
apoptosis	NULL
signal	NULL
,	NULL
it	NULL
may	NULL
be	NULL
important	NULL
that	NULL
quantitatively	NULL
minor	NULL
changes	NULL
in	NULL
protein	NULL
expression	NULL
level	NULL
be	NULL
sufficient	NULL
to	NULL
achieve	NULL
this	NULL
end	NULL
.	NULL

Finally	NULL
,	NULL
although	NULL
physiological	NULL
levels	NULL
of	NULL
Bel-x	NULL
alone	NULL
are	NULL
sufficient	NULL
to	NULL
protect	NULL
against	NULL
apoptosis	NULL
,	NULL
the	NULL
fact	NULL
that	NULL
Bfl-1	NULL
also	NULL
is	NULL
induced	NULL
strongly	NULL
by	NULL
CD40	NULL
suggests	NULL
that	NULL
this	NULL
protein	NULL
also	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
protecting	NULL
B	NULL
cells	NULL
.	NULL

Because	NULL
the	NULL
response	NULL
of	NULL
NF-kB	NULL
against	NULL
apoptosis	NULL
must	NULL
be	NULL
rapid	NULL
,	NULL
leaving	NULL
little	NULL
room	NULL
for	NULL
error	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
two	NULL
Bcl-2	NULL
family	NULL
members	NULL
where	NULL
one	NULL
is	NULL
sufficient	NULL
may	NULL
represent	NULL
a	NULL
precautionary	NULL
reserve	NULL
of	NULL
antiapoptotic	NULL
activity	NULL
.	NULL

Note	NULL
.	NULL

During	NULL
the	NULL
preparation	NULL
of	NULL
this	NULL
manuscript	NULL
,	NULL
two	NULL
separate	NULL
studies	NULL
showed	NULL
up-regulation	NULL
of	NULL
Bfl-1/A1	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
signaling	NULL
through	NULL
other	NULL
stimuli	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

We	NULL
thank	NULL
Drs	NULL
.	NULL

David	NULL
Baltimore	NULL
,	NULL
Charles	NULL
Sawyers	NULL
,	NULL
and	NULL
Stephen	NULL
Smale	NULL
for	NULL
their	NULL
critical	NULL
reading	NULL
and	NULL
valuable	NULL
suggestions	NULL
on	NULL
this	NULL
manuscript	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Drs	NULL
.	NULL

Chris	NULL
Denny	NULL
and	NULL
David	NULL
Chang	NULL
for	NULL
their	NULL
technical	NULL
advice	NULL
on	NULL
the	NULL
representational	NULL
difference	NULL
analysis	NULL
protocol	NULL
and	NULL
Shomyseh	NULL
Sanjabi	NULL
,	NULL
as	NULL
well	NULL
as	NULL
Drs	NULL
.	NULL

Thomas	NULL
Parks	NULL
,	NULL
Katrina	NULL
Catron	NULL
,	NULL
Joshy	NULL
Jacob	NULL
,	NULL
and	NULL
Nancy	NULL
Rice	NULL
,	NULL
for	NULL
providing	NULL
valuable	NULL
reagents	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Margaret	NULL
E.	NULL
Early	NULL
and	NULL
Stop	NULL
Cancer	NULL
Foundations	NULL
.	NULL

HHL	NULL
.	NULL

and	NULL
HD	NULL
.	NULL

are	NULL
supported	NULL
by	NULL
a	NULL
University	NULL
of	NULL
California	NULL
at	NULL
Los	NULL
Angeles	NULL
Medical	NULL
Scientist	NULL
Training	NULL
Program	NULL
Training	NULL
Grant	NULL
(	NULL
GM	NULL
08042	NULL
)	NULL
.	NULL

1	NULL
.	NULL

Smith	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Farrah	NULL
,	NULL
T.	NULL
&	NULL
Goodwin	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
76	NULL
,	NULL
959-962	NULL
.	NULL

2	NULL
.	NULL

Callard	NULL
,	NULL
R.	NULL
,	NULL
Armitage	NULL
,	NULL
R.	NULL
,	NULL
Fanslow	NULL
,	NULL
W.	NULL
&	NULL
Spriggs	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
14	NULL
,	NULL
559-564	NULL
.	NULL

3	NULL
.	NULL

Durie	NULL
,	NULL
F.	NULL
H.	NULL
,	NULL
Foy	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Masters	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Laman	NULL
,	NULL
J.	NULL
D.	NULL
&	NULL
Noelle	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
15	NULL
,	NULL
406-411	NULL
.	NULL

4	NULL
.	NULL

Kawabe	NULL
,	NULL
T.	NULL
,	NULL
Naka	NULL
,	NULL
T.	NULL
,	NULL
Yoshida	NULL
,	NULL
K.	NULL
,	NULL
Tanaka	NULL
,	NULL
T.	NULL
,	NULL
Fujiwara	NULL
,	NULL
H.	NULL
,	NULL
Sumatsu	NULL
,	NULL
S.	NULL
,	NULL
Yoshida	NULL
,	NULL
N.	NULL
,	NULL
Kishimoto	NULL
,	NULL
T.	NULL
&	NULL
Kikutani	NULL
,	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
Immunity	NULL
1	NULL
,	NULL
167-178	NULL
.	NULL

5	NULL
.	NULL

Xu	NULL
,	NULL
J.	NULL
,	NULL
Foy	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Lsaman	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Elliott	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Dunn	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Waldschmidt	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Elsemore	NULL
,	NULL
J.	NULL
,	NULL
Noelle	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

&	NULL
Flavell	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Immunity	NULL
1	NULL
,	NULL
423-431	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
(	NULL
1999	NULL
)	NULL
9141	NULL
Grewal	NULL
,	NULL
I.	NULL
S.	NULL
&	NULL
Flavell	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

16	NULL
,	NULL
111-135	NULL
.	NULL

Kehry	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

156	NULL
,	NULL
2345-2348	NULL
.	NULL

Tsubata	NULL
,	NULL
T.	NULL
,	NULL
Wu	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Honjo	NULL
,	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
364	NULL
,	NULL
645-648	NULL
.	NULL

Cleary	NULL
,	NULL
A.	NULL
,	NULL
Fortune	NULL
,	NULL
S.	NULL
,	NULL
Yellin	NULL
,	NULL
M.	NULL
,	NULL
Chess	NULL
,	NULL
L.	NULL
&	NULL
Lederman	NULL
,	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

155	NULL
,	NULL
3329-3337	NULL
.	NULL

Lagresle	NULL
,	NULL
C.	NULL
,	NULL
Mondiere	NULL
,	NULL
P.	NULL
,	NULL
Bella	NULL
,	NULL
C.	NULL
,	NULL
Krammer	NULL
,	NULL
P.	NULL
&	NULL
Defrance	NULL
,	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183	NULL
,	NULL
1377-1388	NULL
.	NULL

Choi	NULL
,	NULL
M.	NULL
,	NULL
Boise	NULL
,	NULL
L.	NULL
,	NULL
Gottschalk	NULL
,	NULL
A.	NULL
,	NULL
Quintans	NULL
,	NULL
J.	NULL
,	NULL
Thompson	NULL
,	NULL
C.	NULL
&	NULL
Klaus	NULL
,	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

25	NULL
,	NULL
1352-1357	NULL
.	NULL

Merino	NULL
,	NULL
R.	NULL
,	NULL
Grillot	NULL
,	NULL
D.	NULL
,	NULL
Simonian	NULL
,	NULL
P.	NULL
,	NULL
Muthukkumar	NULL
,	NULL
S.	NULL
,	NULL
Fanslow	NULL
,	NULL
W.	NULL
,	NULL
Bondada	NULL
,	NULL
S.	NULL
&	NULL
Nunez	NULL
,	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

155	NULL
,	NULL
3830-3838	NULL
.	NULL

Wang	NULL
,	NULL
Z.	NULL
,	NULL
Karras	NULL
,	NULL
J.	NULL
,	NULL
Howard	NULL
,	NULL
R.	NULL
&	NULL
Rothstein	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

155	NULL
,	NULL
3722-3725	NULL
.	NULL

Adams	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Cory	NULL
,	NULL
S.	NULL
(	NULL
1998	NULL
)	NULL
Science	NULL
281	NULL
,	NULL
1322-1326	NULL
.	NULL

Schneider	NULL
,	NULL
T.	NULL
,	NULL
Grillot	NULL
,	NULL
D.	NULL
,	NULL
Foote	NULL
,	NULL
L.	NULL
,	NULL
Nunez	NULL
,	NULL
G.	NULL
&	NULL
Rothstein	NULL
,	NULL
T.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

159	NULL
,	NULL
4834-4839	NULL
.	NULL

Lee	NULL
,	NULL
H.	NULL
,	NULL
Dempsey	NULL
,	NULL
P.	NULL
,	NULL
Parks	NULL
,	NULL
T.	NULL
,	NULL
Zhu	NULL
,	NULL
X.	NULL
,	NULL
Baltimore	NULL
,	NULL
D.	NULL
&	NULL
Cheng	NULL
,	NULL
G.	NULL
(	NULL
1999	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
,	NULL
1421-1426	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
Cell	NULL
87	NULL
,	NULL
13-20	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
Science	NULL
274	NULL
,	NULL
782-784	NULL
.	NULL

Wang	NULL
,	NULL
C.-Y	NULL
.	NULL

,	NULL
Mayo	NULL
,	NULL
M.	NULL
W.	NULL
&	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
(	NULL
1996	NULL
)	NULL
Science	NULL
274	NULL
,	NULL
784-787	NULL
.	NULL

Van	NULL
Antwerp	NULL
,	NULL
D.	NULL
,	NULL
Martin	NULL
,	NULL
S.	NULL
,	NULL
Kafri	NULL
,	NULL
T.	NULL
,	NULL
Green	NULL
,	NULL
D.	NULL
&	NULL
Verma	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Science	NULL
274	NULL
,	NULL
787-789	NULL
.	NULL

Hubank	NULL
,	NULL
M.	NULL
&	NULL
Schatz	NULL
,	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22	NULL
,	NULL
5640-5648	NULL
.	NULL

Chang	NULL
,	NULL
D.	NULL
,	NULL
Park	NULL
,	NULL
N.	NULL
,	NULL
Denny	NULL
,	NULL
C.	NULL
,	NULL
Nelson	NULL
,	NULL
S.	NULL
&	NULL
Pe	NULL
,	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
Oncogene	NULL
16	NULL
,	NULL
1921-1930	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
p.	NULL
,	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
Scott	NULL
,	NULL
M.	NULL
L.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
1354-1363	NULL
.	NULL

Liou	NULL
,	NULL
H.	NULL
,	NULL
Sha	NULL
,	NULL
W.	NULL
,	NULL
Scott	NULL
,	NULL
M.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

14	NULL
,	NULL
5349-5359	NULL
.	NULL

Herrmann	NULL
,	NULL
M.	NULL
,	NULL
Lorenz	NULL
,	NULL
H.	NULL
,	NULL
Voll	NULL
,	NULL
R.	NULL
,	NULL
Grunke	NULL
,	NULL
M.	NULL
,	NULL
Woith	NULL
,	NULL
W.	NULL
&	NULL
Kalden	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22	NULL
,	NULL
5506-5507	NULL
.	NULL

Park	NULL
,	NULL
I.	NULL
,	NULL
Lee	NULL
,	NULL
S.	NULL
,	NULL
Whang	NULL
,	NULL
D.	NULL
,	NULL
Hong	NULL
,	NULL
W.	NULL
,	NULL
Choi	NULL
,	NULL
S.	NULL
,	NULL
Shin	NULL
,	NULL
H.	NULL
,	NULL
Choe	NULL
,	NULL
T.	NULL
&	NULL
Hong	NULL
,	NULL
S.	NULL
(	NULL
1997	NULL
)	NULL
Anticancer	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
4619-4622	NULL
.	NULL

D'Sa-Eipper	NULL
,	NULL
C.	NULL
&	NULL
Chinnadurai	NULL
,	NULL
G.	NULL
(	NULL
1998	NULL
)	NULL
Oncogene	NULL
16	NULL
,	NULL
3105-3114	NULL
.	NULL

Lin	NULL
,	NULL
E.	NULL
,	NULL
Orlofsky	NULL
,	NULL
A.	NULL
,	NULL
Berger	NULL
,	NULL
M.	NULL
&	NULL
Prystowsky	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

151	NULL
,	NULL
1979-1988	NULL
.	NULL

Karsan	NULL
,	NULL
A.	NULL
,	NULL
Yee	NULL
,	NULL
E.	NULL
,	NULL
Kaushansky	NULL
,	NULL
K.	NULL
&	NULL
Harlan	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Blood	NULL
87	NULL
,	NULL
3089-3096	NULL
.	NULL

Hu	NULL
,	NULL
X.	NULL
,	NULL
Yee	NULL
,	NULL
E.	NULL
,	NULL
Harlan	NULL
,	NULL
J.	NULL
,	NULL
Wong	NULL
,	NULL
F.	NULL
&	NULL
Karsan	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Blood	NULL
92	NULL
,	NULL
2759-2765	NULL
.	NULL

Littlewood	NULL
,	NULL
T.	NULL
,	NULL
Hancock	NULL
,	NULL
D.	NULL
,	NULL
Danielian	NULL
,	NULL
P.	NULL
,	NULL
Parker	NULL
,	NULL
M.	NULL
&	NULL
Evan	NULL
,	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

23	NULL
,	NULL
1686-1690	NULL
.	NULL

Baldwin	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14	NULL
,	NULL
649-683	NULL
.	NULL

Chu	NULL
,	NULL
Z.	NULL
,	NULL
McKinsey	NULL
,	NULL
T.	NULL
,	NULL
Liu	NULL
,	NULL
L.	NULL
,	NULL
Gentry	NULL
,	NULL
J.	NULL
,	NULL
Malim	NULL
,	NULL
M.	NULL
&	NULL
Ballard	NULL
,	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
,	NULL
10057-10062	NULL
.	NULL

Wang	NULL
,	NULL
C.	NULL
,	NULL
Mayo	NULL
,	NULL
M.	NULL
,	NULL
Korneluk	NULL
,	NULL
R.	NULL
,	NULL
Goeddel	NULL
,	NULL
D.	NULL
&	NULL
Baldwin	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Science	NULL
281	NULL
,	NULL
1680-1683	NULL
.	NULL

Wu	NULL
,	NULL
M.	NULL
,	NULL
Ao	NULL
,	NULL
Z.	NULL
,	NULL
Prasad	NULL
,	NULL
K.	NULL
,	NULL
Wu	NULL
,	NULL
R.	NULL
&	NULL
Schlossman	NULL
,	NULL
S.	NULL
(	NULL
1998	NULL
)	NULL
Science	NULL
281	NULL
,	NULL
998-1001	NULL
.	NULL

Krikos	NULL
,	NULL
A.	NULL
,	NULL
Laherty	NULL
,	NULL
C.	NULL
&	NULL
Dixit	NULL
,	NULL
V.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
17971-17976	NULL
.	NULL

Banchereau	NULL
,	NULL
J.	NULL
,	NULL
Bazan	NULL
,	NULL
F.	NULL
,	NULL
Blanchard	NULL
,	NULL
D.	NULL
,	NULL
Briere	NULL
,	NULL
F.	NULL
,	NULL
Galizzi	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Kooten	NULL
,	NULL
C.	NULL
v.	NULL
,	NULL
Liu	NULL
,	NULL
Y.	NULL
J.	NULL
,	NULL
Rousset	NULL
,	NULL
F.	NULL
&	NULL
Saeland	NULL
,	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12	NULL
,	NULL
881-992	NULL
.	NULL

Rothstein	NULL
,	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

8	NULL
,	NULL
362-371	NULL
.	NULL

Zhang	NULL
,	NULL
X.	NULL
,	NULL
Li	NULL
,	NULL
L.	NULL
,	NULL
Choe	NULL
,	NULL
J.	NULL
,	NULL
Krajewski	NULL
,	NULL
S.	NULL
,	NULL
Reed	NULL
,	NULL
J.	NULL
,	NULL
Thompson	NULL
,	NULL
C.	NULL
&	NULL
Choi	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Cell	NULL
.	NULL

Immunol	NULL
.	NULL

173	NULL
,	NULL
149-154	NULL
.	NULL

Grumont	NULL
,	NULL
R.	NULL
,	NULL
Rourke	NULL
,	NULL
I	NULL
.	NULL

&	NULL
Gerondakis	NULL
,	NULL
S.	NULL
(	NULL
1999	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

13	NULL
,	NULL
400-411	NULL
.	NULL

Zong	NULL
,	NULL
W.	NULL
,	NULL
Edelstein	NULL
,	NULL
L.	NULL
,	NULL
Chen	NULL
,	NULL
C.	NULL
,	NULL
Bash	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Gelinas	NULL
,	NULL
C.	NULL
(	NULL
1999	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

13	NULL
,	NULL
382-387	NULL
.	NULL

